ONTOLOGY	ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
BP	GO:0098883	synapse pruning	2/50	11/18670	0.0003807	0.1719	0.154	C1QA/C3	2
BP	GO:0002863	positive regulation of inflammatory response to antigenic stimulus	2/50	12/18670	0.000456	0.1719	0.154	C3/CCR7	2
BP	GO:0002864	regulation of acute inflammatory response to antigenic stimulus	2/50	13/18670	0.000538	0.1719	0.154	C3/CCR7	2
BP	GO:0016322	neuron remodeling	2/50	13/18670	0.000538	0.1719	0.154	C1QA/C3	2
BP	GO:0002673	regulation of acute inflammatory response	4/50	159/18670	0.00086	0.2198	0.197	C1QA/APCS/C3/CCR7	4
BP	GO:0002922	positive regulation of humoral immune response	2/50	19/18670	0.001167	0.2487	0.2228	C3/CCR7	2
BP	GO:0002438	acute inflammatory response to antigenic stimulus	2/50	21/18670	0.001429	0.2609	0.2338	C3/CCR7	2
BP	GO:0002861	regulation of inflammatory response to antigenic stimulus	2/50	24/18670	0.001868	0.2985	0.2675	C3/CCR7	2
BP	GO:0002526	acute inflammatory response	4/50	220/18670	0.002827	0.3141	0.2815	C1QA/APCS/C3/CCR7	4
BP	GO:0006362	transcription elongation from RNA polymerase I promoter	2/50	30/18670	0.002915	0.3141	0.2815	TAF1B/ERCC2	2
BP	GO:0002675	positive regulation of acute inflammatory response	2/50	31/18670	0.00311	0.3141	0.2815	C3/CCR7	2
BP	GO:0006363	termination of RNA polymerase I transcription	2/50	31/18670	0.00311	0.3141	0.2815	TAF1B/ERCC2	2
BP	GO:0006361	transcription initiation from RNA polymerase I promoter	2/50	36/18670	0.004178	0.3141	0.2815	TAF1B/ERCC2	2
BP	GO:0045911	positive regulation of DNA recombination	2/50	39/18670	0.004889	0.3141	0.2815	ERCC2/PRDM7	2
BP	GO:0030099	myeloid cell differentiation	5/50	416/18670	0.004987	0.3141	0.2815	THPO/ACVR2A/ERCC2/APCS/CCR7	5
BP	GO:0002920	regulation of humoral immune response	3/50	134/18670	0.00554	0.3141	0.2815	C1QA/C3/CCR7	3
BP	GO:0006958	complement activation, classical pathway	3/50	137/18670	0.00589	0.3141	0.2815	C1QA/APCS/C3	3
BP	GO:0010828	positive regulation of glucose transmembrane transport	2/50	44/18670	0.006189	0.3141	0.2815	C3/NFE2L2	2
BP	GO:0002437	inflammatory response to antigenic stimulus	2/50	46/18670	0.006748	0.3141	0.2815	C3/CCR7	2
BP	GO:0021700	developmental maturation	4/50	284/18670	0.006972	0.3141	0.2815	RAB3A/ERCC2/C1QA/C3	4
BP	GO:0042551	neuron maturation	2/50	47/18670	0.007036	0.3141	0.2815	C1QA/C3	2
BP	GO:2000107	negative regulation of leukocyte apoptotic process	2/50	47/18670	0.007036	0.3141	0.2815	NOC2L/CCR7	2
BP	GO:0061041	regulation of wound healing	3/50	148/18670	0.007287	0.3141	0.2815	RAB3A/APCS/NFE2L2	3
BP	GO:0002455	humoral immune response mediated by circulating immunoglobulin	3/50	150/18670	0.00756	0.3141	0.2815	C1QA/APCS/C3	3
BP	GO:1903018	regulation of glycoprotein metabolic process	2/50	49/18670	0.007628	0.3141	0.2815	APCS/CCR7	2
BP	GO:0043551	regulation of phosphatidylinositol 3-kinase activity	2/50	55/18670	0.009535	0.3141	0.2815	PIK3R5/CCR7	2
BP	GO:0071695	anatomical structure maturation	3/50	165/18670	0.009803	0.3141	0.2815	ERCC2/C1QA/C3	3
BP	GO:0010665	regulation of cardiac muscle cell apoptotic process	2/50	57/18670	0.01021	0.3141	0.2815	LTK/NFE2L2	2
BP	GO:0010662	regulation of striated muscle cell apoptotic process	2/50	59/18670	0.01091	0.3141	0.2815	LTK/NFE2L2	2
BP	GO:0010659	cardiac muscle cell apoptotic process	2/50	60/18670	0.01127	0.3141	0.2815	LTK/NFE2L2	2
BP	GO:0006956	complement activation	3/50	175/18670	0.01149	0.3141	0.2815	C1QA/APCS/C3	3
BP	GO:0051897	positive regulation of protein kinase B signaling	3/50	176/18670	0.01167	0.3141	0.2815	THPO/PIK3R5/CCR7	3
BP	GO:0048469	cell maturation	3/50	177/18670	0.01185	0.3141	0.2815	ERCC2/C1QA/C3	3
BP	GO:0010658	striated muscle cell apoptotic process	2/50	62/18670	0.012	0.3141	0.2815	LTK/NFE2L2	2
BP	GO:1903034	regulation of response to wounding	3/50	179/18670	0.01221	0.3141	0.2815	RAB3A/APCS/NFE2L2	3
BP	GO:0006360	transcription by RNA polymerase I	2/50	64/18670	0.01275	0.3141	0.2815	TAF1B/ERCC2	2
BP	GO:0043550	regulation of lipid kinase activity	2/50	64/18670	0.01275	0.3141	0.2815	PIK3R5/CCR7	2
BP	GO:0003002	regionalization	4/50	351/18670	0.01434	0.3141	0.2815	IRX3/ACVR2A/C1QA/C3	4
BP	GO:0002449	lymphocyte mediated immunity	4/50	352/18670	0.01447	0.3141	0.2815	CD1B/C1QA/APCS/C3	4
BP	GO:0006959	humoral immune response	4/50	356/18670	0.01503	0.3141	0.2815	C1QA/APCS/C3/CCR7	4
BP	GO:0061515	myeloid cell development	2/50	70/18670	0.01512	0.3141	0.2815	THPO/ERCC2	2
BP	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	4/50	361/18670	0.01574	0.3141	0.2815	CD1B/C1QA/APCS/C3	4
BP	GO:0072376	protein activation cascade	3/50	198/18670	0.01598	0.3141	0.2815	C1QA/APCS/C3	3
BP	GO:0006353	DNA-templated transcription, termination	2/50	75/18670	0.01722	0.3141	0.2815	TAF1B/ERCC2	2
BP	GO:0045666	positive regulation of neuron differentiation	4/50	371/18670	0.01723	0.3141	0.2815	IRX3/LTK/ADRA2B/NFE2L2	4
BP	GO:0010827	regulation of glucose transmembrane transport	2/50	78/18670	0.01854	0.3141	0.2815	C3/NFE2L2	2
BP	GO:0031346	positive regulation of cell projection organization	4/50	383/18670	0.01913	0.3141	0.2815	LTK/NFE2L2/CCR7/PLEK2	4
BP	GO:0016064	immunoglobulin mediated immune response	3/50	218/18670	0.02058	0.3141	0.2815	C1QA/APCS/C3	3
BP	GO:0060218	hematopoietic stem cell differentiation	2/50	83/18670	0.02084	0.3141	0.2815	ERCC2/NFE2L2	2
BP	GO:2000106	regulation of leukocyte apoptotic process	2/50	83/18670	0.02084	0.3141	0.2815	NOC2L/CCR7	2
BP	GO:0019724	B cell mediated immunity	3/50	221/18670	0.02133	0.3141	0.2815	C1QA/APCS/C3	3
BP	GO:0009791	post-embryonic development	2/50	88/18670	0.02324	0.3141	0.2815	RAB3A/ERCC2	2
BP	GO:0070098	chemokine-mediated signaling pathway	2/50	88/18670	0.02324	0.3141	0.2815	THPO/CCR7	2
BP	GO:1903725	regulation of phospholipid metabolic process	2/50	88/18670	0.02324	0.3141	0.2815	PIK3R5/CCR7	2
BP	GO:0019216	regulation of lipid metabolic process	4/50	410/18670	0.02387	0.3141	0.2815	PIK3R5/C3/LPGAT1/CCR7	4
BP	GO:0001656	metanephros development	2/50	90/18670	0.02423	0.3141	0.2815	IRX3/FRAS1	2
BP	GO:0001578	microtubule bundle formation	2/50	91/18670	0.02474	0.3141	0.2815	TRIM46/TTLL1	2
BP	GO:0045639	positive regulation of myeloid cell differentiation	2/50	91/18670	0.02474	0.3141	0.2815	THPO/ACVR2A	2
BP	GO:0060993	kidney morphogenesis	2/50	94/18670	0.02627	0.3141	0.2815	IRX3/FRAS1	2
BP	GO:0001768	establishment of T cell polarity	1/50	10/18670	0.02647	0.3141	0.2815	CCR7	1
BP	GO:0043084	penile erection	1/50	10/18670	0.02647	0.3141	0.2815	ACVR2A	1
BP	GO:0044359	modulation of molecular function in other organism	1/50	10/18670	0.02647	0.3141	0.2815	APCS	1
BP	GO:0052205	modulation of molecular function in other organism involved in symbiotic interaction	1/50	10/18670	0.02647	0.3141	0.2815	APCS	1
BP	GO:0070472	regulation of uterine smooth muscle contraction	1/50	10/18670	0.02647	0.3141	0.2815	ADRA2B	1
BP	GO:0071233	cellular response to leucine	1/50	10/18670	0.02647	0.3141	0.2815	RRAGD	1
BP	GO:0072610	interleukin-12 secretion	1/50	10/18670	0.02647	0.3141	0.2815	CCR7	1
BP	GO:0097048	dendritic cell apoptotic process	1/50	10/18670	0.02647	0.3141	0.2815	CCR7	1
BP	GO:0097278	complement-dependent cytotoxicity	1/50	10/18670	0.02647	0.3141	0.2815	C3	1
BP	GO:1902033	regulation of hematopoietic stem cell proliferation	1/50	10/18670	0.02647	0.3141	0.2815	THPO	1
BP	GO:1902513	regulation of organelle transport along microtubule	1/50	10/18670	0.02647	0.3141	0.2815	TRIM46	1
BP	GO:1990253	cellular response to leucine starvation	1/50	10/18670	0.02647	0.3141	0.2815	RRAGD	1
BP	GO:2000425	regulation of apoptotic cell clearance	1/50	10/18670	0.02647	0.3141	0.2815	C3	1
BP	GO:2000668	regulation of dendritic cell apoptotic process	1/50	10/18670	0.02647	0.3141	0.2815	CCR7	1
BP	GO:0010660	regulation of muscle cell apoptotic process	2/50	96/18670	0.02732	0.3141	0.2815	LTK/NFE2L2	2
BP	GO:0051896	regulation of protein kinase B signaling	3/50	244/18670	0.02754	0.3141	0.2815	THPO/PIK3R5/CCR7	3
BP	GO:1990868	response to chemokine	2/50	97/18670	0.02784	0.3141	0.2815	THPO/CCR7	2
BP	GO:1990869	cellular response to chemokine	2/50	97/18670	0.02784	0.3141	0.2815	THPO/CCR7	2
BP	GO:0048872	homeostasis of number of cells	3/50	246/18670	0.02812	0.3141	0.2815	ACVR2A/ERCC2/CCR7	3
BP	GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	2/50	98/18670	0.02838	0.3141	0.2815	NOC2L/NFE2L2	2
BP	GO:0001767	establishment of lymphocyte polarity	1/50	11/18670	0.02908	0.3141	0.2815	CCR7	1
BP	GO:0001778	plasma membrane repair	1/50	11/18670	0.02908	0.3141	0.2815	RAB3A	1
BP	GO:0002604	regulation of dendritic cell antigen processing and presentation	1/50	11/18670	0.02908	0.3141	0.2815	CCR7	1
BP	GO:0006853	carnitine shuttle	1/50	11/18670	0.02908	0.3141	0.2815	SLC25A20	1
BP	GO:0018095	protein polyglutamylation	1/50	11/18670	0.02908	0.3141	0.2815	TTLL1	1
BP	GO:0043619	regulation of transcription from RNA polymerase II promoter in response to oxidative stress	1/50	11/18670	0.02908	0.3141	0.2815	NFE2L2	1
BP	GO:0044793	negative regulation by host of viral process	1/50	11/18670	0.02908	0.3141	0.2815	APCS	1
BP	GO:0045060	negative thymic T cell selection	1/50	11/18670	0.02908	0.3141	0.2815	CCR7	1
BP	GO:0070471	uterine smooth muscle contraction	1/50	11/18670	0.02908	0.3141	0.2815	ADRA2B	1
BP	GO:0072070	loop of Henle development	1/50	11/18670	0.02908	0.3141	0.2815	IRX3	1
BP	GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	2/50	100/18670	0.02945	0.3141	0.2815	CD1B/C3	2
BP	GO:0010657	muscle cell apoptotic process	2/50	100/18670	0.02945	0.3141	0.2815	LTK/NFE2L2	2
BP	GO:0120034	positive regulation of plasma membrane bounded cell projection assembly	2/50	100/18670	0.02945	0.3141	0.2815	CCR7/PLEK2	2
BP	GO:0045637	regulation of myeloid cell differentiation	3/50	251/18670	0.02961	0.3141	0.2815	THPO/ACVR2A/APCS	3
BP	GO:0000018	regulation of DNA recombination	2/50	101/18670	0.03	0.3141	0.2815	ERCC2/PRDM7	2
BP	GO:0007389	pattern specification process	4/50	446/18670	0.03121	0.3141	0.2815	IRX3/ACVR2A/C1QA/C3	4
BP	GO:0048863	stem cell differentiation	3/50	257/18670	0.03144	0.3141	0.2815	PHACTR4/ERCC2/NFE2L2	3
BP	GO:0071887	leukocyte apoptotic process	2/50	104/18670	0.03165	0.3141	0.2815	NOC2L/CCR7	2
BP	GO:0002468	dendritic cell antigen processing and presentation	1/50	12/18670	0.03168	0.3141	0.2815	CCR7	1
BP	GO:0002674	negative regulation of acute inflammatory response	1/50	12/18670	0.03168	0.3141	0.2815	APCS	1
BP	GO:0002903	negative regulation of B cell apoptotic process	1/50	12/18670	0.03168	0.3141	0.2815	NOC2L	1
BP	GO:0007288	sperm axoneme assembly	1/50	12/18670	0.03168	0.3141	0.2815	TTLL1	1
BP	GO:0007320	insemination	1/50	12/18670	0.03168	0.3141	0.2815	ACVR2A	1
BP	GO:0015697	quaternary ammonium group transport	1/50	12/18670	0.03168	0.3141	0.2815	SLC25A20	1
BP	GO:0016188	synaptic vesicle maturation	1/50	12/18670	0.03168	0.3141	0.2815	RAB3A	1
BP	GO:0032252	secretory granule localization	1/50	12/18670	0.03168	0.3141	0.2815	TRIM46	1
BP	GO:0043383	negative T cell selection	1/50	12/18670	0.03168	0.3141	0.2815	CCR7	1
BP	GO:0048484	enteric nervous system development	1/50	12/18670	0.03168	0.3141	0.2815	PHACTR4	1
BP	GO:0060900	embryonic camera-type eye formation	1/50	12/18670	0.03168	0.3141	0.2815	PHACTR4	1
BP	GO:2000121	regulation of removal of superoxide radicals	1/50	12/18670	0.03168	0.3141	0.2815	NFE2L2	1
BP	GO:0002708	positive regulation of lymphocyte mediated immunity	2/50	105/18670	0.03221	0.3141	0.2815	CD1B/C3	2
BP	GO:0002821	positive regulation of adaptive immune response	2/50	105/18670	0.03221	0.3141	0.2815	CD1B/C3	2
BP	GO:1904659	glucose transmembrane transport	2/50	108/18670	0.03392	0.3141	0.2815	C3/NFE2L2	2
BP	GO:0006703	estrogen biosynthetic process	1/50	13/18670	0.03427	0.3141	0.2815	RDH8	1
BP	GO:0009650	UV protection	1/50	13/18670	0.03427	0.3141	0.2815	ERCC2	1
BP	GO:0016558	protein import into peroxisome matrix	1/50	13/18670	0.03427	0.3141	0.2815	PEX10	1
BP	GO:0031274	positive regulation of pseudopodium assembly	1/50	13/18670	0.03427	0.3141	0.2815	CCR7	1
BP	GO:0043201	response to leucine	1/50	13/18670	0.03427	0.3141	0.2815	RRAGD	1
BP	GO:0060100	positive regulation of phagocytosis, engulfment	1/50	13/18670	0.03427	0.3141	0.2815	C3	1
BP	GO:1903651	positive regulation of cytoplasmic transport	1/50	13/18670	0.03427	0.3141	0.2815	TRIM46	1
BP	GO:1905155	positive regulation of membrane invagination	1/50	13/18670	0.03427	0.3141	0.2815	C3	1
BP	GO:0043491	protein kinase B signaling	3/50	269/18670	0.03528	0.3141	0.2815	THPO/PIK3R5/CCR7	3
BP	GO:0006354	DNA-templated transcription, elongation	2/50	112/18670	0.03625	0.3141	0.2815	TAF1B/ERCC2	2
BP	GO:0008645	hexose transmembrane transport	2/50	112/18670	0.03625	0.3141	0.2815	C3/NFE2L2	2
BP	GO:0001771	immunological synapse formation	1/50	14/18670	0.03686	0.3141	0.2815	CCR7	1
BP	GO:0031272	regulation of pseudopodium assembly	1/50	14/18670	0.03686	0.3141	0.2815	CCR7	1
BP	GO:0045836	positive regulation of meiotic nuclear division	1/50	14/18670	0.03686	0.3141	0.2815	PRDM7	1
BP	GO:0050862	positive regulation of T cell receptor signaling pathway	1/50	14/18670	0.03686	0.3141	0.2815	CCR7	1
BP	GO:1904263	positive regulation of TORC1 signaling	1/50	14/18670	0.03686	0.3141	0.2815	RRAGD	1
BP	GO:2001044	regulation of integrin-mediated signaling pathway	1/50	14/18670	0.03686	0.3141	0.2815	PHACTR4	1
BP	GO:0015749	monosaccharide transmembrane transport	2/50	114/18670	0.03743	0.3141	0.2815	C3/NFE2L2	2
BP	GO:0030218	erythrocyte differentiation	2/50	114/18670	0.03743	0.3141	0.2815	ACVR2A/ERCC2	2
BP	GO:0030282	bone mineralization	2/50	114/18670	0.03743	0.3141	0.2815	ACVR2A/ERCC2	2
BP	GO:0050769	positive regulation of neurogenesis	4/50	474/18670	0.03776	0.3141	0.2815	IRX3/LTK/ADRA2B/NFE2L2	4
BP	GO:1903706	regulation of hemopoiesis	4/50	475/18670	0.038	0.3141	0.2815	THPO/ACVR2A/APCS/NFE2L2	4
BP	GO:0030449	regulation of complement activation	2/50	115/18670	0.03803	0.3141	0.2815	C1QA/C3	2
BP	GO:0021782	glial cell development	2/50	116/18670	0.03863	0.3141	0.2815	ERCC2/C1QA	2
BP	GO:0034219	carbohydrate transmembrane transport	2/50	116/18670	0.03863	0.3141	0.2815	C3/NFE2L2	2
BP	GO:2000257	regulation of protein activation cascade	2/50	116/18670	0.03863	0.3141	0.2815	C1QA/C3	2
BP	GO:0043666	regulation of phosphoprotein phosphatase activity	2/50	117/18670	0.03924	0.3141	0.2815	PHACTR4/PPP1R12A	2
BP	GO:0006388	tRNA splicing, via endonucleolytic cleavage and ligation	1/50	15/18670	0.03944	0.3141	0.2815	TSEN54	1
BP	GO:0018158	protein oxidation	1/50	15/18670	0.03944	0.3141	0.2815	LOXL1	1
BP	GO:0033604	negative regulation of catecholamine secretion	1/50	15/18670	0.03944	0.3141	0.2815	ADRA2B	1
BP	GO:0034616	response to laminar fluid shear stress	1/50	15/18670	0.03944	0.3141	0.2815	NFE2L2	1
BP	GO:0035067	negative regulation of histone acetylation	1/50	15/18670	0.03944	0.3141	0.2815	NOC2L	1
BP	GO:0042762	regulation of sulfur metabolic process	1/50	15/18670	0.03944	0.3141	0.2815	NFE2L2	1
BP	GO:0043249	erythrocyte maturation	1/50	15/18670	0.03944	0.3141	0.2815	ERCC2	1
BP	GO:0048172	regulation of short-term neuronal synaptic plasticity	1/50	15/18670	0.03944	0.3141	0.2815	RAB3A	1
BP	GO:0060099	regulation of phagocytosis, engulfment	1/50	15/18670	0.03944	0.3141	0.2815	C3	1
BP	GO:0099558	maintenance of synapse structure	1/50	15/18670	0.03944	0.3141	0.2815	RAB3A	1
BP	GO:1903729	regulation of plasma membrane organization	1/50	15/18670	0.03944	0.3141	0.2815	RAB3A	1
BP	GO:0050727	regulation of inflammatory response	4/50	485/18670	0.04053	0.3141	0.2815	C1QA/APCS/C3/CCR7	4
BP	GO:0000394	RNA splicing, via endonucleolytic cleavage and ligation	1/50	16/18670	0.04202	0.3141	0.2815	TSEN54	1
BP	GO:0002475	antigen processing and presentation via MHC class Ib	1/50	16/18670	0.04202	0.3141	0.2815	CD1B	1
BP	GO:0006957	complement activation, alternative pathway	1/50	16/18670	0.04202	0.3141	0.2815	C3	1
BP	GO:0014061	regulation of norepinephrine secretion	1/50	16/18670	0.04202	0.3141	0.2815	ADRA2B	1
BP	GO:0031269	pseudopodium assembly	1/50	16/18670	0.04202	0.3141	0.2815	CCR7	1
BP	GO:0048820	hair follicle maturation	1/50	16/18670	0.04202	0.3141	0.2815	ERCC2	1
BP	GO:0072488	ammonium transmembrane transport	1/50	16/18670	0.04202	0.3141	0.2815	SLC25A20	1
BP	GO:0097091	synaptic vesicle clustering	1/50	16/18670	0.04202	0.3141	0.2815	RAB3A	1
BP	GO:1902001	fatty acid transmembrane transport	1/50	16/18670	0.04202	0.3141	0.2815	SLC25A20	1
BP	GO:1904294	positive regulation of ERAD pathway	1/50	16/18670	0.04202	0.3141	0.2815	NFE2L2	1
BP	GO:1905153	regulation of membrane invagination	1/50	16/18670	0.04202	0.3141	0.2815	C3	1
BP	GO:0034101	erythrocyte homeostasis	2/50	122/18670	0.04232	0.3141	0.2815	ACVR2A/ERCC2	2
BP	GO:0001838	embryonic epithelial tube formation	2/50	124/18670	0.04358	0.3141	0.2815	IRX3/PHACTR4	2
BP	GO:0006750	glutathione biosynthetic process	1/50	17/18670	0.04458	0.3141	0.2815	NFE2L2	1
BP	GO:0007379	segment specification	1/50	17/18670	0.04458	0.3141	0.2815	IRX3	1
BP	GO:0015919	peroxisomal membrane transport	1/50	17/18670	0.04458	0.3141	0.2815	PEX10	1
BP	GO:0031268	pseudopodium organization	1/50	17/18670	0.04458	0.3141	0.2815	CCR7	1
BP	GO:0035855	megakaryocyte development	1/50	17/18670	0.04458	0.3141	0.2815	THPO	1
BP	GO:0042790	nucleolar large rRNA transcription by RNA polymerase I	1/50	17/18670	0.04458	0.3141	0.2815	TAF1B	1
BP	GO:0048243	norepinephrine secretion	1/50	17/18670	0.04458	0.3141	0.2815	ADRA2B	1
BP	GO:0002902	regulation of B cell apoptotic process	1/50	18/18670	0.04714	0.3141	0.2815	NOC2L	1
BP	GO:0036148	phosphatidylglycerol acyl-chain remodeling	1/50	18/18670	0.04714	0.3141	0.2815	LPGAT1	1
BP	GO:0072079	nephron tubule formation	1/50	18/18670	0.04714	0.3141	0.2815	IRX3	1
BP	GO:1903019	negative regulation of glycoprotein metabolic process	1/50	18/18670	0.04714	0.3141	0.2815	APCS	1
BP	GO:2000757	negative regulation of peptidyl-lysine acetylation	1/50	18/18670	0.04714	0.3141	0.2815	NOC2L	1
BP	GO:0072175	epithelial tube formation	2/50	132/18670	0.04875	0.3141	0.2815	IRX3/PHACTR4	2
BP	GO:0002705	positive regulation of leukocyte mediated immunity	2/50	133/18670	0.04941	0.3141	0.2815	CD1B/C3	2
BP	GO:0010663	positive regulation of striated muscle cell apoptotic process	1/50	19/18670	0.0497	0.3141	0.2815	LTK	1
BP	GO:0010666	positive regulation of cardiac muscle cell apoptotic process	1/50	19/18670	0.0497	0.3141	0.2815	LTK	1
BP	GO:0016082	synaptic vesicle priming	1/50	19/18670	0.0497	0.3141	0.2815	RAB3A	1
BP	GO:0019184	nonribosomal peptide biosynthetic process	1/50	19/18670	0.0497	0.3141	0.2815	NFE2L2	1
BP	GO:0032288	myelin assembly	1/50	19/18670	0.0497	0.3141	0.2815	ERCC2	1
BP	GO:0046597	negative regulation of viral entry into host cell	1/50	19/18670	0.0497	0.3141	0.2815	APCS	1
BP	GO:0048490	anterograde synaptic vesicle transport	1/50	19/18670	0.0497	0.3141	0.2815	TRIM46	1
BP	GO:0051131	chaperone-mediated protein complex assembly	1/50	19/18670	0.0497	0.3141	0.2815	APCS	1
BP	GO:0071731	response to nitric oxide	1/50	19/18670	0.0497	0.3141	0.2815	CCR7	1
BP	GO:0099514	synaptic vesicle cytoskeletal transport	1/50	19/18670	0.0497	0.3141	0.2815	TRIM46	1
BP	GO:0099517	synaptic vesicle transport along microtubule	1/50	19/18670	0.0497	0.3141	0.2815	TRIM46	1
BP	GO:1902176	negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	1/50	19/18670	0.0497	0.3141	0.2815	NFE2L2	1
BP	GO:0007498	mesoderm development	2/50	135/18670	0.05074	0.3141	0.2815	IRX3/ACVR2A	2
BP	GO:0002577	regulation of antigen processing and presentation	1/50	20/18670	0.05225	0.3141	0.2815	CCR7	1
BP	GO:0007620	copulation	1/50	20/18670	0.05225	0.3141	0.2815	ACVR2A	1
BP	GO:0010560	positive regulation of glycoprotein biosynthetic process	1/50	20/18670	0.05225	0.3141	0.2815	CCR7	1
BP	GO:0045655	regulation of monocyte differentiation	1/50	20/18670	0.05225	0.3141	0.2815	APCS	1
BP	GO:0035304	regulation of protein dephosphorylation	2/50	139/18670	0.05345	0.3141	0.2815	PHACTR4/PPP1R12A	2
BP	GO:0007568	aging	3/50	321/18670	0.05459	0.3141	0.2815	ERCC2/C1QA/NFE2L2	3
BP	GO:0006293	nucleotide-excision repair, preincision complex stabilization	1/50	21/18670	0.05479	0.3141	0.2815	ERCC2	1
BP	GO:0006295	nucleotide-excision repair, DNA incision, 3'-to lesion	1/50	21/18670	0.05479	0.3141	0.2815	ERCC2	1
BP	GO:0015874	norepinephrine transport	1/50	21/18670	0.05479	0.3141	0.2815	ADRA2B	1
BP	GO:0032516	positive regulation of phosphoprotein phosphatase activity	1/50	21/18670	0.05479	0.3141	0.2815	PPP1R12A	1
BP	GO:0036499	PERK-mediated unfolded protein response	1/50	21/18670	0.05479	0.3141	0.2815	NFE2L2	1
BP	GO:0045061	thymic T cell selection	1/50	21/18670	0.05479	0.3141	0.2815	CCR7	1
BP	GO:0071498	cellular response to fluid shear stress	1/50	21/18670	0.05479	0.3141	0.2815	NFE2L2	1
BP	GO:1904753	negative regulation of vascular associated smooth muscle cell migration	1/50	21/18670	0.05479	0.3141	0.2815	NFE2L2	1
BP	GO:2000737	negative regulation of stem cell differentiation	1/50	21/18670	0.05479	0.3141	0.2815	NFE2L2	1
BP	GO:0009411	response to UV	2/50	141/18670	0.05482	0.3141	0.2815	ERCC2/NOC2L	2
BP	GO:0032103	positive regulation of response to external stimulus	3/50	323/18670	0.05541	0.3141	0.2815	C3/CCR7/CD180	3
BP	GO:0000717	nucleotide-excision repair, DNA duplex unwinding	1/50	22/18670	0.05732	0.3141	0.2815	ERCC2	1
BP	GO:0006312	mitotic recombination	1/50	22/18670	0.05732	0.3141	0.2815	ERCC2	1
BP	GO:0010866	regulation of triglyceride biosynthetic process	1/50	22/18670	0.05732	0.3141	0.2815	C3	1
BP	GO:0010884	positive regulation of lipid storage	1/50	22/18670	0.05732	0.3141	0.2815	C3	1
BP	GO:0019883	antigen processing and presentation of endogenous antigen	1/50	22/18670	0.05732	0.3141	0.2815	CD1B	1
BP	GO:0022010	central nervous system myelination	1/50	22/18670	0.05732	0.3141	0.2815	ERCC2	1
BP	GO:0031629	synaptic vesicle fusion to presynaptic active zone membrane	1/50	22/18670	0.05732	0.3141	0.2815	RAB3A	1
BP	GO:0032069	regulation of nuclease activity	1/50	22/18670	0.05732	0.3141	0.2815	OAS2	1
BP	GO:0032291	axon ensheathment in central nervous system	1/50	22/18670	0.05732	0.3141	0.2815	ERCC2	1
BP	GO:0045723	positive regulation of fatty acid biosynthetic process	1/50	22/18670	0.05732	0.3141	0.2815	LPGAT1	1
BP	GO:1901522	positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus	1/50	22/18670	0.05732	0.3141	0.2815	NFE2L2	1
BP	GO:1901984	negative regulation of protein acetylation	1/50	22/18670	0.05732	0.3141	0.2815	NOC2L	1
BP	GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	2/50	145/18670	0.0576	0.3141	0.2815	CD1B/C3	2
BP	GO:0045834	positive regulation of lipid metabolic process	2/50	146/18670	0.0583	0.3141	0.2815	LPGAT1/CCR7	2
BP	GO:0032496	response to lipopolysaccharide	3/50	330/18670	0.05835	0.3141	0.2815	LOXL1/CCR7/CD180	3
BP	GO:0002262	myeloid cell homeostasis	2/50	147/18670	0.05901	0.3141	0.2815	ACVR2A/ERCC2	2
BP	GO:0008643	carbohydrate transport	2/50	148/18670	0.05972	0.3141	0.2815	C3/NFE2L2	2
BP	GO:0014065	phosphatidylinositol 3-kinase signaling	2/50	148/18670	0.05972	0.3141	0.2815	PIK3R5/LTK	2
BP	GO:0035148	tube formation	2/50	148/18670	0.05972	0.3141	0.2815	IRX3/PHACTR4	2
BP	GO:0010499	proteasomal ubiquitin-independent protein catabolic process	1/50	23/18670	0.05985	0.3141	0.2815	NFE2L2	1
BP	GO:0034695	response to prostaglandin E	1/50	23/18670	0.05985	0.3141	0.2815	CCR7	1
BP	GO:0045109	intermediate filament organization	1/50	23/18670	0.05985	0.3141	0.2815	DES	1
BP	GO:0060294	cilium movement involved in cell motility	1/50	23/18670	0.05985	0.3141	0.2815	TTLL1	1
BP	GO:0071425	hematopoietic stem cell proliferation	1/50	23/18670	0.05985	0.3141	0.2815	THPO	1
BP	GO:0099500	vesicle fusion to plasma membrane	1/50	23/18670	0.05985	0.3141	0.2815	RAB3A	1
BP	GO:1901032	negative regulation of response to reactive oxygen species	1/50	23/18670	0.05985	0.3141	0.2815	NFE2L2	1
BP	GO:1903206	negative regulation of hydrogen peroxide-induced cell death	1/50	23/18670	0.05985	0.3141	0.2815	NFE2L2	1
BP	GO:2001039	negative regulation of cellular response to drug	1/50	23/18670	0.05985	0.3141	0.2815	NFE2L2	1
BP	GO:0071902	positive regulation of protein serine/threonine kinase activity	3/50	334/18670	0.06007	0.3141	0.2815	PIK3R5/ADRA2B/CCND2	3
BP	GO:0002706	regulation of lymphocyte mediated immunity	2/50	149/18670	0.06043	0.3141	0.2815	CD1B/C3	2
BP	GO:0009267	cellular response to starvation	2/50	149/18670	0.06043	0.3141	0.2815	RRAGD/NFE2L2	2
BP	GO:0007596	blood coagulation	3/50	336/18670	0.06093	0.3141	0.2815	PIK3R5/ADRA2B/NFE2L2	3
BP	GO:0016331	morphogenesis of embryonic epithelium	2/50	150/18670	0.06114	0.3141	0.2815	IRX3/PHACTR4	2
BP	GO:0001783	B cell apoptotic process	1/50	24/18670	0.06237	0.3141	0.2815	NOC2L	1
BP	GO:0002407	dendritic cell chemotaxis	1/50	24/18670	0.06237	0.3141	0.2815	CCR7	1
BP	GO:0003351	epithelial cilium movement	1/50	24/18670	0.06237	0.3141	0.2815	TTLL1	1
BP	GO:0032925	regulation of activin receptor signaling pathway	1/50	24/18670	0.06237	0.3141	0.2815	ACVR2A	1
BP	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	1/50	24/18670	0.06237	0.3141	0.2815	CCR7	1
BP	GO:0051446	positive regulation of meiotic cell cycle	1/50	24/18670	0.06237	0.3141	0.2815	PRDM7	1
BP	GO:0090023	positive regulation of neutrophil chemotaxis	1/50	24/18670	0.06237	0.3141	0.2815	CCR7	1
BP	GO:1903020	positive regulation of glycoprotein metabolic process	1/50	24/18670	0.06237	0.3141	0.2815	CCR7	1
BP	GO:1903649	regulation of cytoplasmic transport	1/50	24/18670	0.06237	0.3141	0.2815	TRIM46	1
BP	GO:0048489	synaptic vesicle transport	2/50	152/18670	0.06258	0.3141	0.2815	RAB3A/TRIM46	2
BP	GO:0097480	establishment of synaptic vesicle localization	2/50	152/18670	0.06258	0.3141	0.2815	RAB3A/TRIM46	2
BP	GO:0007599	hemostasis	3/50	341/18670	0.06312	0.3141	0.2815	PIK3R5/ADRA2B/NFE2L2	3
BP	GO:0030168	platelet activation	2/50	153/18670	0.0633	0.3141	0.2815	PIK3R5/ADRA2B	2
BP	GO:0050729	positive regulation of inflammatory response	2/50	153/18670	0.0633	0.3141	0.2815	C3/CCR7	2
BP	GO:0050817	coagulation	3/50	342/18670	0.06356	0.3141	0.2815	PIK3R5/ADRA2B/NFE2L2	3
BP	GO:0001101	response to acid chemical	3/50	343/18670	0.06401	0.3141	0.2815	RRAGD/LTK/CCR7	3
BP	GO:0002237	response to molecule of bacterial origin	3/50	343/18670	0.06401	0.3141	0.2815	LOXL1/CCR7/CD180	3
BP	GO:1903707	negative regulation of hemopoiesis	2/50	155/18670	0.06476	0.3141	0.2815	APCS/NFE2L2	2
BP	GO:0009404	toxin metabolic process	1/50	25/18670	0.06488	0.3141	0.2815	NFE2L2	1
BP	GO:0014829	vascular smooth muscle contraction	1/50	25/18670	0.06488	0.3141	0.2815	ADRA2B	1
BP	GO:0019430	removal of superoxide radicals	1/50	25/18670	0.06488	0.3141	0.2815	NFE2L2	1
BP	GO:0031664	regulation of lipopolysaccharide-mediated signaling pathway	1/50	25/18670	0.06488	0.3141	0.2815	CD180	1
BP	GO:1904385	cellular response to angiotensin	1/50	25/18670	0.06488	0.3141	0.2815	NFE2L2	1
BP	GO:0001764	neuron migration	2/50	157/18670	0.06622	0.3167	0.2838	TRIM46/LRP12	2
BP	GO:0001916	positive regulation of T cell mediated cytotoxicity	1/50	26/18670	0.06739	0.3167	0.2838	CD1B	1
BP	GO:0030194	positive regulation of blood coagulation	1/50	26/18670	0.06739	0.3167	0.2838	NFE2L2	1
BP	GO:0048596	embryonic camera-type eye morphogenesis	1/50	26/18670	0.06739	0.3167	0.2838	PHACTR4	1
BP	GO:0070911	global genome nucleotide-excision repair	1/50	26/18670	0.06739	0.3167	0.2838	ERCC2	1
BP	GO:0071624	positive regulation of granulocyte chemotaxis	1/50	26/18670	0.06739	0.3167	0.2838	CCR7	1
BP	GO:1900048	positive regulation of hemostasis	1/50	26/18670	0.06739	0.3167	0.2838	NFE2L2	1
BP	GO:0002819	regulation of adaptive immune response	2/50	160/18670	0.06844	0.3167	0.2838	CD1B/C3	2
BP	GO:0036336	dendritic cell migration	1/50	27/18670	0.06989	0.3167	0.2838	CCR7	1
BP	GO:0048143	astrocyte activation	1/50	27/18670	0.06989	0.3167	0.2838	C1QA	1
BP	GO:0050820	positive regulation of coagulation	1/50	27/18670	0.06989	0.3167	0.2838	NFE2L2	1
BP	GO:0051953	negative regulation of amine transport	1/50	27/18670	0.06989	0.3167	0.2838	ADRA2B	1
BP	GO:0071450	cellular response to oxygen radical	1/50	27/18670	0.06989	0.3167	0.2838	NFE2L2	1
BP	GO:0071451	cellular response to superoxide	1/50	27/18670	0.06989	0.3167	0.2838	NFE2L2	1
BP	GO:1902175	regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	1/50	27/18670	0.06989	0.3167	0.2838	NFE2L2	1
BP	GO:0031214	biomineral tissue development	2/50	163/18670	0.07069	0.3167	0.2838	ACVR2A/ERCC2	2
BP	GO:0097479	synaptic vesicle localization	2/50	163/18670	0.07069	0.3167	0.2838	RAB3A/TRIM46	2
BP	GO:2001242	regulation of intrinsic apoptotic signaling pathway	2/50	165/18670	0.0722	0.3167	0.2838	NOC2L/NFE2L2	2
BP	GO:0043687	post-translational protein modification	3/50	361/18670	0.07224	0.3167	0.2838	RAB3A/SPSB2/C3	3
BP	GO:0001702	gastrulation with mouth forming second	1/50	28/18670	0.07239	0.3167	0.2838	ACVR2A	1
BP	GO:1990776	response to angiotensin	1/50	28/18670	0.07239	0.3167	0.2838	NFE2L2	1
BP	GO:0002244	hematopoietic progenitor cell differentiation	2/50	166/18670	0.07296	0.3167	0.2838	ERCC2/NFE2L2	2
BP	GO:0001906	cell killing	2/50	168/18670	0.07448	0.3167	0.2838	CD1B/C3	2
BP	GO:0150063	visual system development	3/50	366/18670	0.07461	0.3167	0.2838	PHACTR4/C1QA/C3	3
BP	GO:0000303	response to superoxide	1/50	29/18670	0.07488	0.3167	0.2838	NFE2L2	1
BP	GO:0003016	respiratory system process	1/50	29/18670	0.07488	0.3167	0.2838	RAB3A	1
BP	GO:0006294	nucleotide-excision repair, preincision complex assembly	1/50	29/18670	0.07488	0.3167	0.2838	ERCC2	1
BP	GO:0010575	positive regulation of vascular endothelial growth factor production	1/50	29/18670	0.07488	0.3167	0.2838	C3	1
BP	GO:0010954	positive regulation of protein processing	1/50	29/18670	0.07488	0.3167	0.2838	C3	1
BP	GO:0018200	peptidyl-glutamic acid modification	1/50	29/18670	0.07488	0.3167	0.2838	TTLL1	1
BP	GO:0044788	modulation by host of viral process	1/50	29/18670	0.07488	0.3167	0.2838	APCS	1
BP	GO:0060632	regulation of microtubule-based movement	1/50	29/18670	0.07488	0.3167	0.2838	TRIM46	1
BP	GO:0070229	negative regulation of lymphocyte apoptotic process	1/50	29/18670	0.07488	0.3167	0.2838	NOC2L	1
BP	GO:0071280	cellular response to copper ion	1/50	29/18670	0.07488	0.3167	0.2838	NFE2L2	1
BP	GO:1902624	positive regulation of neutrophil migration	1/50	29/18670	0.07488	0.3167	0.2838	CCR7	1
BP	GO:0030198	extracellular matrix organization	3/50	368/18670	0.07557	0.3167	0.2838	LOXL1/ERCC2/COL9A2	3
BP	GO:0048880	sensory system development	3/50	371/18670	0.07701	0.3167	0.2838	PHACTR4/C1QA/C3	3
BP	GO:0000305	response to oxygen radical	1/50	30/18670	0.07736	0.3167	0.2838	NFE2L2	1
BP	GO:0007274	neuromuscular synaptic transmission	1/50	30/18670	0.07736	0.3167	0.2838	RAB3A	1
BP	GO:0046596	regulation of viral entry into host cell	1/50	30/18670	0.07736	0.3167	0.2838	APCS	1
BP	GO:0051491	positive regulation of filopodium assembly	1/50	30/18670	0.07736	0.3167	0.2838	CCR7	1
BP	GO:0090022	regulation of neutrophil chemotaxis	1/50	30/18670	0.07736	0.3167	0.2838	CCR7	1
BP	GO:1903205	regulation of hydrogen peroxide-induced cell death	1/50	30/18670	0.07736	0.3167	0.2838	NFE2L2	1
BP	GO:1904292	regulation of ERAD pathway	1/50	30/18670	0.07736	0.3167	0.2838	NFE2L2	1
BP	GO:0006790	sulfur compound metabolic process	3/50	372/18670	0.0775	0.3167	0.2838	GAL3ST4/ACSF2/NFE2L2	3
BP	GO:0002888	positive regulation of myeloid leukocyte mediated immunity	1/50	31/18670	0.07983	0.3167	0.2838	C3	1
BP	GO:0009954	proximal/distal pattern formation	1/50	31/18670	0.07983	0.3167	0.2838	IRX3	1
BP	GO:0031338	regulation of vesicle fusion	1/50	31/18670	0.07983	0.3167	0.2838	RAB3A	1
BP	GO:0034694	response to prostaglandin	1/50	31/18670	0.07983	0.3167	0.2838	CCR7	1
BP	GO:0040020	regulation of meiotic nuclear division	1/50	31/18670	0.07983	0.3167	0.2838	PRDM7	1
BP	GO:0045648	positive regulation of erythrocyte differentiation	1/50	31/18670	0.07983	0.3167	0.2838	ACVR2A	1
BP	GO:0045737	positive regulation of cyclin-dependent protein serine/threonine kinase activity	1/50	31/18670	0.07983	0.3167	0.2838	CCND2	1
BP	GO:0046471	phosphatidylglycerol metabolic process	1/50	31/18670	0.07983	0.3167	0.2838	LPGAT1	1
BP	GO:0071880	adenylate cyclase-activating adrenergic receptor signaling pathway	1/50	31/18670	0.07983	0.3167	0.2838	ADRA2B	1
BP	GO:1903319	positive regulation of protein maturation	1/50	31/18670	0.07983	0.3167	0.2838	C3	1
BP	GO:0010921	regulation of phosphatase activity	2/50	175/18670	0.0799	0.3167	0.2838	PHACTR4/PPP1R12A	2
BP	GO:0120032	regulation of plasma membrane bounded cell projection assembly	2/50	175/18670	0.0799	0.3167	0.2838	CCR7/PLEK2	2
BP	GO:0060491	regulation of cell projection assembly	2/50	177/18670	0.08147	0.3167	0.2838	CCR7/PLEK2	2
BP	GO:0003338	metanephros morphogenesis	1/50	32/18670	0.0823	0.3167	0.2838	FRAS1	1
BP	GO:0008210	estrogen metabolic process	1/50	32/18670	0.0823	0.3167	0.2838	RDH8	1
BP	GO:0043552	positive regulation of phosphatidylinositol 3-kinase activity	1/50	32/18670	0.0823	0.3167	0.2838	CCR7	1
BP	GO:0045745	positive regulation of G protein-coupled receptor signaling pathway	1/50	32/18670	0.0823	0.3167	0.2838	C3	1
BP	GO:0045987	positive regulation of smooth muscle contraction	1/50	32/18670	0.0823	0.3167	0.2838	ADRA2B	1
BP	GO:0006631	fatty acid metabolic process	3/50	383/18670	0.08292	0.3167	0.2838	C3/ACSF2/LPGAT1	3
BP	GO:0070613	regulation of protein processing	2/50	180/18670	0.08385	0.3167	0.2838	C1QA/C3	2
BP	GO:0048015	phosphatidylinositol-mediated signaling	2/50	181/18670	0.08464	0.3167	0.2838	PIK3R5/LTK	2
BP	GO:0001914	regulation of T cell mediated cytotoxicity	1/50	33/18670	0.08476	0.3167	0.2838	CD1B	1
BP	GO:0006370	7-methylguanosine mRNA capping	1/50	33/18670	0.08476	0.3167	0.2838	ERCC2	1
BP	GO:0006891	intra-Golgi vesicle-mediated transport	1/50	33/18670	0.08476	0.3167	0.2838	COPB2	1
BP	GO:0009303	rRNA transcription	1/50	33/18670	0.08476	0.3167	0.2838	TAF1B	1
BP	GO:0010039	response to iron ion	1/50	33/18670	0.08476	0.3167	0.2838	C1QA	1
BP	GO:0036003	positive regulation of transcription from RNA polymerase II promoter in response to stress	1/50	33/18670	0.08476	0.3167	0.2838	NFE2L2	1
BP	GO:0048821	erythrocyte development	1/50	33/18670	0.08476	0.3167	0.2838	ERCC2	1
BP	GO:0051194	positive regulation of cofactor metabolic process	1/50	33/18670	0.08476	0.3167	0.2838	NFE2L2	1
BP	GO:2000352	negative regulation of endothelial cell apoptotic process	1/50	33/18670	0.08476	0.3167	0.2838	NFE2L2	1
BP	GO:2001024	negative regulation of response to drug	1/50	33/18670	0.08476	0.3167	0.2838	NFE2L2	1
BP	GO:2001038	regulation of cellular response to drug	1/50	33/18670	0.08476	0.3167	0.2838	NFE2L2	1
BP	GO:1903317	regulation of protein maturation	2/50	182/18670	0.08544	0.3167	0.2838	C1QA/C3	2
BP	GO:0048017	inositol lipid-mediated signaling	2/50	184/18670	0.08705	0.3167	0.2838	PIK3R5/LTK	2
BP	GO:0009452	7-methylguanosine RNA capping	1/50	34/18670	0.08722	0.3167	0.2838	ERCC2	1
BP	GO:0010574	regulation of vascular endothelial growth factor production	1/50	34/18670	0.08722	0.3167	0.2838	C3	1
BP	GO:0010922	positive regulation of phosphatase activity	1/50	34/18670	0.08722	0.3167	0.2838	PPP1R12A	1
BP	GO:0032148	activation of protein kinase B activity	1/50	34/18670	0.08722	0.3167	0.2838	ADRA2B	1
BP	GO:0036260	RNA capping	1/50	34/18670	0.08722	0.3167	0.2838	ERCC2	1
BP	GO:0036474	cell death in response to hydrogen peroxide	1/50	34/18670	0.08722	0.3167	0.2838	NFE2L2	1
BP	GO:0048048	embryonic eye morphogenesis	1/50	34/18670	0.08722	0.3167	0.2838	PHACTR4	1
BP	GO:0071875	adrenergic receptor signaling pathway	1/50	34/18670	0.08722	0.3167	0.2838	ADRA2B	1
BP	GO:0097009	energy homeostasis	1/50	34/18670	0.08722	0.3167	0.2838	IRX3	1
BP	GO:1903708	positive regulation of hemopoiesis	2/50	185/18670	0.08785	0.3181	0.285	THPO/ACVR2A	2
BP	GO:0015695	organic cation transport	1/50	35/18670	0.08967	0.321	0.2877	SLC25A20	1
BP	GO:0032735	positive regulation of interleukin-12 production	1/50	35/18670	0.08967	0.321	0.2877	CCR7	1
BP	GO:0098751	bone cell development	1/50	35/18670	0.08967	0.321	0.2877	THPO	1
BP	GO:1904031	positive regulation of cyclin-dependent protein kinase activity	1/50	35/18670	0.08967	0.321	0.2877	CCND2	1
BP	GO:0018205	peptidyl-lysine modification	3/50	397/18670	0.09005	0.3214	0.288	LOXL1/NOC2L/PRDM7	3
BP	GO:0010573	vascular endothelial growth factor production	1/50	36/18670	0.09211	0.3214	0.288	C3	1
BP	GO:0030224	monocyte differentiation	1/50	36/18670	0.09211	0.3214	0.288	APCS	1
BP	GO:0090218	positive regulation of lipid kinase activity	1/50	36/18670	0.09211	0.3214	0.288	CCR7	1
BP	GO:0090322	regulation of superoxide metabolic process	1/50	36/18670	0.09211	0.3214	0.288	NFE2L2	1
BP	GO:0097242	amyloid-beta clearance	1/50	36/18670	0.09211	0.3214	0.288	C3	1
BP	GO:1902622	regulation of neutrophil migration	1/50	36/18670	0.09211	0.3214	0.288	CCR7	1
BP	GO:1903131	mononuclear cell differentiation	1/50	36/18670	0.09211	0.3214	0.288	APCS	1
BP	GO:0042594	response to starvation	2/50	191/18670	0.09273	0.3214	0.288	RRAGD/NFE2L2	2
BP	GO:0002714	positive regulation of B cell mediated immunity	1/50	37/18670	0.09455	0.3214	0.288	C3	1
BP	GO:0002891	positive regulation of immunoglobulin mediated immune response	1/50	37/18670	0.09455	0.3214	0.288	C3	1
BP	GO:0006296	nucleotide-excision repair, DNA incision, 5'-to lesion	1/50	37/18670	0.09455	0.3214	0.288	ERCC2	1
BP	GO:0014912	negative regulation of smooth muscle cell migration	1/50	37/18670	0.09455	0.3214	0.288	NFE2L2	1
BP	GO:0031076	embryonic camera-type eye development	1/50	37/18670	0.09455	0.3214	0.288	PHACTR4	1
BP	GO:0034405	response to fluid shear stress	1/50	37/18670	0.09455	0.3214	0.288	NFE2L2	1
BP	GO:0045777	positive regulation of blood pressure	1/50	37/18670	0.09455	0.3214	0.288	ADRA2B	1
BP	GO:0045923	positive regulation of fatty acid metabolic process	1/50	37/18670	0.09455	0.3214	0.288	LPGAT1	1
BP	GO:1903432	regulation of TORC1 signaling	1/50	37/18670	0.09455	0.3214	0.288	RRAGD	1
BP	GO:2000273	positive regulation of signaling receptor activity	1/50	37/18670	0.09455	0.3214	0.288	ADRA2B	1
BP	GO:0050808	synapse organization	3/50	408/18670	0.09584	0.3232	0.2897	RAB3A/C1QA/C3	3
BP	GO:0007340	acrosome reaction	1/50	38/18670	0.09698	0.3232	0.2897	RAB3A	1
BP	GO:0010667	negative regulation of cardiac muscle cell apoptotic process	1/50	38/18670	0.09698	0.3232	0.2897	NFE2L2	1
BP	GO:0046326	positive regulation of glucose import	1/50	38/18670	0.09698	0.3232	0.2897	NFE2L2	1
BP	GO:1905898	positive regulation of response to endoplasmic reticulum stress	1/50	38/18670	0.09698	0.3232	0.2897	NFE2L2	1
BP	GO:0046890	regulation of lipid biosynthetic process	2/50	198/18670	0.09853	0.3232	0.2897	C3/LPGAT1	2
BP	GO:0046486	glycerolipid metabolic process	3/50	414/18670	0.09905	0.3232	0.2897	PIK3R5/C3/LPGAT1	3
BP	GO:0001539	cilium or flagellum-dependent cell motility	1/50	39/18670	0.0994	0.3232	0.2897	TTLL1	1
BP	GO:0010661	positive regulation of muscle cell apoptotic process	1/50	39/18670	0.0994	0.3232	0.2897	LTK	1
BP	GO:0030049	muscle filament sliding	1/50	39/18670	0.0994	0.3232	0.2897	DES	1
BP	GO:0030501	positive regulation of bone mineralization	1/50	39/18670	0.0994	0.3232	0.2897	ACVR2A	1
BP	GO:0033275	actin-myosin filament sliding	1/50	39/18670	0.0994	0.3232	0.2897	DES	1
BP	GO:0033683	nucleotide-excision repair, DNA incision	1/50	39/18670	0.0994	0.3232	0.2897	ERCC2	1
BP	GO:0050856	regulation of T cell receptor signaling pathway	1/50	39/18670	0.0994	0.3232	0.2897	CCR7	1
BP	GO:0060285	cilium-dependent cell motility	1/50	39/18670	0.0994	0.3232	0.2897	TTLL1	1
BP	GO:1901998	toxin transport	1/50	39/18670	0.0994	0.3232	0.2897	COPB2	1
BP	GO:2000648	positive regulation of stem cell proliferation	1/50	39/18670	0.0994	0.3232	0.2897	THPO	1
BP	GO:0002703	regulation of leukocyte mediated immunity	2/50	201/18670	0.101	0.3261	0.2922	CD1B/C3	2
BP	GO:0009100	glycoprotein metabolic process	3/50	419/18670	0.1018	0.3261	0.2922	GAL3ST4/APCS/CCR7	3
BP	GO:0007618	mating	1/50	40/18670	0.1018	0.3261	0.2922	ACVR2A	1
BP	GO:0032008	positive regulation of TOR signaling	1/50	40/18670	0.1018	0.3261	0.2922	RRAGD	1
BP	GO:0035315	hair cell differentiation	1/50	40/18670	0.1018	0.3261	0.2922	ERCC2	1
BP	GO:0090207	regulation of triglyceride metabolic process	1/50	40/18670	0.1018	0.3261	0.2922	C3	1
BP	GO:0043062	extracellular structure organization	3/50	422/18670	0.1034	0.3263	0.2924	LOXL1/ERCC2/COL9A2	3
BP	GO:0002573	myeloid leukocyte differentiation	2/50	204/18670	0.1036	0.3263	0.2924	APCS/CCR7	2
BP	GO:0034764	positive regulation of transmembrane transport	2/50	204/18670	0.1036	0.3263	0.2924	C3/NFE2L2	2
BP	GO:0045766	positive regulation of angiogenesis	2/50	204/18670	0.1036	0.3263	0.2924	C3/NFE2L2	2
BP	GO:0032386	regulation of intracellular transport	3/50	423/18670	0.104	0.3263	0.2924	RAB3A/PPP1R12A/TRIM46	3
BP	GO:0010664	negative regulation of striated muscle cell apoptotic process	1/50	41/18670	0.1042	0.3263	0.2924	NFE2L2	1
BP	GO:0019432	triglyceride biosynthetic process	1/50	41/18670	0.1042	0.3263	0.2924	C3	1
BP	GO:0042572	retinol metabolic process	1/50	41/18670	0.1042	0.3263	0.2924	RDH8	1
BP	GO:0044743	protein transmembrane import into intracellular organelle	1/50	41/18670	0.1042	0.3263	0.2924	PEX10	1
BP	GO:0099003	vesicle-mediated transport in synapse	2/50	207/18670	0.1061	0.3263	0.2924	RAB3A/TRIM46	2
BP	GO:0010559	regulation of glycoprotein biosynthetic process	1/50	42/18670	0.1066	0.3263	0.2924	CCR7	1
BP	GO:0030517	negative regulation of axon extension	1/50	42/18670	0.1066	0.3263	0.2924	TRIM46	1
BP	GO:0031057	negative regulation of histone modification	1/50	42/18670	0.1066	0.3263	0.2924	NOC2L	1
BP	GO:0042149	cellular response to glucose starvation	1/50	42/18670	0.1066	0.3263	0.2924	NFE2L2	1
BP	GO:0097028	dendritic cell differentiation	1/50	42/18670	0.1066	0.3263	0.2924	CCR7	1
BP	GO:1901031	regulation of response to reactive oxygen species	1/50	42/18670	0.1066	0.3263	0.2924	NFE2L2	1
BP	GO:0035303	regulation of dephosphorylation	2/50	209/18670	0.1078	0.3263	0.2924	PHACTR4/PPP1R12A	2
BP	GO:0071229	cellular response to acid chemical	2/50	209/18670	0.1078	0.3263	0.2924	RRAGD/LTK	2
BP	GO:0006644	phospholipid metabolic process	3/50	430/18670	0.1078	0.3263	0.2924	PIK3R5/LPGAT1/CCR7	3
BP	GO:0006904	vesicle docking involved in exocytosis	1/50	43/18670	0.109	0.3263	0.2924	RAB3A	1
BP	GO:0008631	intrinsic apoptotic signaling pathway in response to oxidative stress	1/50	43/18670	0.109	0.3263	0.2924	NFE2L2	1
BP	GO:0032365	intracellular lipid transport	1/50	43/18670	0.109	0.3263	0.2924	SLC25A20	1
BP	GO:0032924	activin receptor signaling pathway	1/50	43/18670	0.109	0.3263	0.2924	ACVR2A	1
BP	GO:0034198	cellular response to amino acid starvation	1/50	43/18670	0.109	0.3263	0.2924	RRAGD	1
BP	GO:0038202	TORC1 signaling	1/50	43/18670	0.109	0.3263	0.2924	RRAGD	1
BP	GO:0046460	neutral lipid biosynthetic process	1/50	43/18670	0.109	0.3263	0.2924	C3	1
BP	GO:0046463	acylglycerol biosynthetic process	1/50	43/18670	0.109	0.3263	0.2924	C3	1
BP	GO:0051602	response to electrical stimulus	1/50	43/18670	0.109	0.3263	0.2924	RAB3A	1
BP	GO:0014002	astrocyte development	1/50	44/18670	0.1114	0.3273	0.2933	C1QA	1
BP	GO:0014003	oligodendrocyte development	1/50	44/18670	0.1114	0.3273	0.2933	ERCC2	1
BP	GO:0014047	glutamate secretion	1/50	44/18670	0.1114	0.3273	0.2933	RAB3A	1
BP	GO:0035307	positive regulation of protein dephosphorylation	1/50	44/18670	0.1114	0.3273	0.2933	PPP1R12A	1
BP	GO:0046688	response to copper ion	1/50	44/18670	0.1114	0.3273	0.2933	NFE2L2	1
BP	GO:0051489	regulation of filopodium assembly	1/50	44/18670	0.1114	0.3273	0.2933	CCR7	1
BP	GO:0070897	transcription preinitiation complex assembly	1/50	44/18670	0.1114	0.3273	0.2933	TAF1B	1
BP	GO:0071622	regulation of granulocyte chemotaxis	1/50	44/18670	0.1114	0.3273	0.2933	CCR7	1
BP	GO:0070374	positive regulation of ERK1 and ERK2 cascade	2/50	215/18670	0.113	0.3312	0.2968	THPO/CCR7	2
BP	GO:0002833	positive regulation of response to biotic stimulus	1/50	45/18670	0.1138	0.3314	0.297	CD180	1
BP	GO:0048483	autonomic nervous system development	1/50	45/18670	0.1138	0.3314	0.297	PHACTR4	1
BP	GO:0002699	positive regulation of immune effector process	2/50	216/18670	0.1139	0.3314	0.297	CD1B/C3	2
BP	GO:0010001	glial cell differentiation	2/50	218/18670	0.1156	0.3314	0.297	ERCC2/C1QA	2
BP	GO:0006984	ER-nucleus signaling pathway	1/50	46/18670	0.1162	0.3314	0.297	NFE2L2	1
BP	GO:0010883	regulation of lipid storage	1/50	46/18670	0.1162	0.3314	0.297	C3	1
BP	GO:0043277	apoptotic cell clearance	1/50	46/18670	0.1162	0.3314	0.297	C3	1
BP	GO:0050706	regulation of interleukin-1 beta secretion	1/50	46/18670	0.1162	0.3314	0.297	CCR7	1
BP	GO:1904036	negative regulation of epithelial cell apoptotic process	1/50	46/18670	0.1162	0.3314	0.297	NFE2L2	1
BP	GO:1904738	vascular associated smooth muscle cell migration	1/50	46/18670	0.1162	0.3314	0.297	NFE2L2	1
BP	GO:1904752	regulation of vascular associated smooth muscle cell migration	1/50	46/18670	0.1162	0.3314	0.297	NFE2L2	1
BP	GO:1990928	response to amino acid starvation	1/50	46/18670	0.1162	0.3314	0.297	RRAGD	1
BP	GO:0006953	acute-phase response	1/50	47/18670	0.1186	0.3316	0.2972	APCS	1
BP	GO:0045058	T cell selection	1/50	47/18670	0.1186	0.3316	0.2972	CCR7	1
BP	GO:0045646	regulation of erythrocyte differentiation	1/50	47/18670	0.1186	0.3316	0.2972	ACVR2A	1
BP	GO:0047496	vesicle transport along microtubule	1/50	47/18670	0.1186	0.3316	0.2972	TRIM46	1
BP	GO:0051181	cofactor transport	1/50	47/18670	0.1186	0.3316	0.2972	SLC25A20	1
BP	GO:0070169	positive regulation of biomineral tissue development	1/50	47/18670	0.1186	0.3316	0.2972	ACVR2A	1
BP	GO:0044706	multi-multicellular organism process	2/50	222/18670	0.1191	0.3316	0.2972	ACVR2A/ADRA2B	2
BP	GO:0006979	response to oxidative stress	3/50	451/18670	0.1198	0.3316	0.2972	ERCC2/NFE2L2/CCR7	3
BP	GO:0001774	microglial cell activation	1/50	48/18670	0.1209	0.3316	0.2972	C1QA	1
BP	GO:0002269	leukocyte activation involved in inflammatory response	1/50	48/18670	0.1209	0.3316	0.2972	C1QA	1
BP	GO:0002711	positive regulation of T cell mediated immunity	1/50	48/18670	0.1209	0.3316	0.2972	CD1B	1
BP	GO:0002762	negative regulation of myeloid leukocyte differentiation	1/50	48/18670	0.1209	0.3316	0.2972	APCS	1
BP	GO:0007595	lactation	1/50	48/18670	0.1209	0.3316	0.2972	OAS2	1
BP	GO:0008089	anterograde axonal transport	1/50	48/18670	0.1209	0.3316	0.2972	TRIM46	1
BP	GO:0009311	oligosaccharide metabolic process	1/50	48/18670	0.1209	0.3316	0.2972	GAL3ST4	1
BP	GO:0010862	positive regulation of pathway-restricted SMAD protein phosphorylation	1/50	48/18670	0.1209	0.3316	0.2972	ACVR2A	1
BP	GO:0045933	positive regulation of muscle contraction	1/50	48/18670	0.1209	0.3316	0.2972	ADRA2B	1
BP	GO:1903727	positive regulation of phospholipid metabolic process	1/50	48/18670	0.1209	0.3316	0.2972	CCR7	1
BP	GO:0045665	negative regulation of neuron differentiation	2/50	225/18670	0.1218	0.3332	0.2986	IRX3/TRIM46	2
BP	GO:0019882	antigen processing and presentation	2/50	226/18670	0.1226	0.3349	0.3001	CD1B/CCR7	2
BP	GO:0001913	T cell mediated cytotoxicity	1/50	49/18670	0.1233	0.3352	0.3004	CD1B	1
BP	GO:0051445	regulation of meiotic cell cycle	1/50	49/18670	0.1233	0.3352	0.3004	PRDM7	1
BP	GO:0002697	regulation of immune effector process	3/50	458/18670	0.1239	0.3363	0.3014	CD1B/C1QA/C3	3
BP	GO:0051054	positive regulation of DNA metabolic process	2/50	228/18670	0.1244	0.3369	0.3019	ERCC2/PRDM7	2
BP	GO:0042398	cellular modified amino acid biosynthetic process	1/50	50/18670	0.1256	0.3373	0.3022	NFE2L2	1
BP	GO:0045104	intermediate filament cytoskeleton organization	1/50	50/18670	0.1256	0.3373	0.3022	DES	1
BP	GO:1900087	positive regulation of G1/S transition of mitotic cell cycle	1/50	50/18670	0.1256	0.3373	0.3022	CCND2	1
BP	GO:1904018	positive regulation of vasculature development	2/50	230/18670	0.1262	0.3373	0.3022	C3/NFE2L2	2
BP	GO:2001234	negative regulation of apoptotic signaling pathway	2/50	230/18670	0.1262	0.3373	0.3022	NOC2L/NFE2L2	2
BP	GO:0001954	positive regulation of cell-matrix adhesion	1/50	51/18670	0.128	0.3373	0.3022	CCR7	1
BP	GO:0002712	regulation of B cell mediated immunity	1/50	51/18670	0.128	0.3373	0.3022	C3	1
BP	GO:0002889	regulation of immunoglobulin mediated immune response	1/50	51/18670	0.128	0.3373	0.3022	C3	1
BP	GO:0045103	intermediate filament-based process	1/50	51/18670	0.128	0.3373	0.3022	DES	1
BP	GO:0048260	positive regulation of receptor-mediated endocytosis	1/50	51/18670	0.128	0.3373	0.3022	C3	1
BP	GO:0050999	regulation of nitric-oxide synthase activity	1/50	51/18670	0.128	0.3373	0.3022	ACVR2A	1
BP	GO:0097366	response to bronchodilator	1/50	51/18670	0.128	0.3373	0.3022	CCR7	1
BP	GO:0000302	response to reactive oxygen species	2/50	232/18670	0.128	0.3373	0.3022	NFE2L2/CCR7	2
BP	GO:0043254	regulation of protein complex assembly	3/50	467/18670	0.1293	0.34	0.3047	RAB3A/ERCC2/CCR7	3
BP	GO:0031529	ruffle organization	1/50	52/18670	0.1303	0.3406	0.3052	CCR7	1
BP	GO:0048168	regulation of neuronal synaptic plasticity	1/50	52/18670	0.1303	0.3406	0.3052	RAB3A	1
BP	GO:0099518	vesicle cytoskeletal trafficking	1/50	52/18670	0.1303	0.3406	0.3052	TRIM46	1
BP	GO:0031669	cellular response to nutrient levels	2/50	237/18670	0.1325	0.3418	0.3063	RRAGD/NFE2L2	2
BP	GO:0007131	reciprocal meiotic recombination	1/50	53/18670	0.1327	0.3418	0.3063	PRDM7	1
BP	GO:0035065	regulation of histone acetylation	1/50	53/18670	0.1327	0.3418	0.3063	NOC2L	1
BP	GO:0050702	interleukin-1 beta secretion	1/50	53/18670	0.1327	0.3418	0.3063	CCR7	1
BP	GO:0050704	regulation of interleukin-1 secretion	1/50	53/18670	0.1327	0.3418	0.3063	CCR7	1
BP	GO:0070228	regulation of lymphocyte apoptotic process	1/50	53/18670	0.1327	0.3418	0.3063	NOC2L	1
BP	GO:1903307	positive regulation of regulated secretory pathway	1/50	53/18670	0.1327	0.3418	0.3063	RAB3A	1
BP	GO:0032655	regulation of interleukin-12 production	1/50	54/18670	0.135	0.3464	0.3104	CCR7	1
BP	GO:0035825	homologous recombination	1/50	54/18670	0.135	0.3464	0.3104	PRDM7	1
BP	GO:0002011	morphogenesis of an epithelial sheet	1/50	55/18670	0.1373	0.3489	0.3126	PHACTR4	1
BP	GO:0002886	regulation of myeloid leukocyte mediated immunity	1/50	55/18670	0.1373	0.3489	0.3126	C3	1
BP	GO:0032781	positive regulation of ATPase activity	1/50	55/18670	0.1373	0.3489	0.3126	RAB3A	1
BP	GO:0042304	regulation of fatty acid biosynthetic process	1/50	55/18670	0.1373	0.3489	0.3126	LPGAT1	1
BP	GO:0043954	cellular component maintenance	1/50	55/18670	0.1373	0.3489	0.3126	RAB3A	1
BP	GO:0001912	positive regulation of leukocyte mediated cytotoxicity	1/50	56/18670	0.1396	0.3499	0.3136	CD1B	1
BP	GO:0006749	glutathione metabolic process	1/50	56/18670	0.1396	0.3499	0.3136	NFE2L2	1
BP	GO:0031295	T cell costimulation	1/50	56/18670	0.1396	0.3499	0.3136	CCR7	1
BP	GO:0032615	interleukin-12 production	1/50	56/18670	0.1396	0.3499	0.3136	CCR7	1
BP	GO:0051568	histone H3-K4 methylation	1/50	56/18670	0.1396	0.3499	0.3136	PRDM7	1
BP	GO:0065002	intracellular protein transmembrane transport	1/50	56/18670	0.1396	0.3499	0.3136	PEX10	1
BP	GO:1903202	negative regulation of oxidative stress-induced cell death	1/50	56/18670	0.1396	0.3499	0.3136	NFE2L2	1
BP	GO:0001755	neural crest cell migration	1/50	57/18670	0.1419	0.3536	0.3169	PHACTR4	1
BP	GO:0031294	lymphocyte costimulation	1/50	57/18670	0.1419	0.3536	0.3169	CCR7	1
BP	GO:1900408	negative regulation of cellular response to oxidative stress	1/50	57/18670	0.1419	0.3536	0.3169	NFE2L2	1
BP	GO:0065004	protein-DNA complex assembly	2/50	248/18670	0.1425	0.3538	0.3171	TAF1B/ERCC2	2
BP	GO:0006352	DNA-templated transcription, initiation	2/50	249/18670	0.1434	0.3538	0.3171	TAF1B/ERCC2	2
BP	GO:0019229	regulation of vasoconstriction	1/50	58/18670	0.1442	0.3538	0.3171	ADRA2B	1
BP	GO:0031663	lipopolysaccharide-mediated signaling pathway	1/50	58/18670	0.1442	0.3538	0.3171	CD180	1
BP	GO:0035306	positive regulation of dephosphorylation	1/50	58/18670	0.1442	0.3538	0.3171	PPP1R12A	1
BP	GO:0035904	aorta development	1/50	58/18670	0.1442	0.3538	0.3171	LOXL1	1
BP	GO:0061900	glial cell activation	1/50	58/18670	0.1442	0.3538	0.3171	C1QA	1
BP	GO:0098930	axonal transport	1/50	58/18670	0.1442	0.3538	0.3171	TRIM46	1
BP	GO:0045017	glycerolipid biosynthetic process	2/50	251/18670	0.1453	0.3547	0.3179	PIK3R5/C3	2
BP	GO:0010656	negative regulation of muscle cell apoptotic process	1/50	59/18670	0.1465	0.3547	0.3179	NFE2L2	1
BP	GO:0043388	positive regulation of DNA binding	1/50	59/18670	0.1465	0.3547	0.3179	ERCC2	1
BP	GO:0046847	filopodium assembly	1/50	59/18670	0.1465	0.3547	0.3179	CCR7	1
BP	GO:1902883	negative regulation of response to oxidative stress	1/50	59/18670	0.1465	0.3547	0.3179	NFE2L2	1
BP	GO:2000351	regulation of endothelial cell apoptotic process	1/50	59/18670	0.1465	0.3547	0.3179	NFE2L2	1
BP	GO:2000756	regulation of peptidyl-lysine acetylation	1/50	59/18670	0.1465	0.3547	0.3179	NOC2L	1
BP	GO:0046324	regulation of glucose import	1/50	60/18670	0.1488	0.3586	0.3213	NFE2L2	1
BP	GO:1902808	positive regulation of cell cycle G1/S phase transition	1/50	60/18670	0.1488	0.3586	0.3213	CCND2	1
BP	GO:0010975	regulation of neuron projection development	3/50	499/18670	0.149	0.3586	0.3213	TRIM46/LTK/NFE2L2	3
BP	GO:0050701	interleukin-1 secretion	1/50	61/18670	0.1511	0.3624	0.3247	CCR7	1
BP	GO:0090303	positive regulation of wound healing	1/50	61/18670	0.1511	0.3624	0.3247	NFE2L2	1
BP	GO:0043406	positive regulation of MAP kinase activity	2/50	258/18670	0.1518	0.3632	0.3255	PIK3R5/ADRA2B	2
BP	GO:0007585	respiratory gaseous exchange	1/50	62/18670	0.1534	0.3636	0.3258	RAB3A	1
BP	GO:0035082	axoneme assembly	1/50	62/18670	0.1534	0.3636	0.3258	TTLL1	1
BP	GO:0050433	regulation of catecholamine secretion	1/50	62/18670	0.1534	0.3636	0.3258	ADRA2B	1
BP	GO:0060393	regulation of pathway-restricted SMAD protein phosphorylation	1/50	62/18670	0.1534	0.3636	0.3258	ACVR2A	1
BP	GO:1905268	negative regulation of chromatin organization	1/50	62/18670	0.1534	0.3636	0.3258	NOC2L	1
BP	GO:0008654	phospholipid biosynthetic process	2/50	260/18670	0.1536	0.3636	0.3258	PIK3R5/LPGAT1	2
BP	GO:0007588	excretion	1/50	63/18670	0.1557	0.3671	0.329	CLCNKA	1
BP	GO:0045815	positive regulation of gene expression, epigenetic	1/50	63/18670	0.1557	0.3671	0.329	TAF1B	1
BP	GO:0032768	regulation of monooxygenase activity	1/50	64/18670	0.158	0.3697	0.3313	ACVR2A	1
BP	GO:0045669	positive regulation of osteoblast differentiation	1/50	64/18670	0.158	0.3697	0.3313	ACVR2A	1
BP	GO:0048278	vesicle docking	1/50	64/18670	0.158	0.3697	0.3313	RAB3A	1
BP	GO:0050432	catecholamine secretion	1/50	64/18670	0.158	0.3697	0.3313	ADRA2B	1
BP	GO:0006940	regulation of smooth muscle contraction	1/50	65/18670	0.1602	0.3709	0.3324	ADRA2B	1
BP	GO:0009247	glycolipid biosynthetic process	1/50	65/18670	0.1602	0.3709	0.3324	GAL3ST4	1
BP	GO:0050854	regulation of antigen receptor-mediated signaling pathway	1/50	65/18670	0.1602	0.3709	0.3324	CCR7	1
BP	GO:0060389	pathway-restricted SMAD protein phosphorylation	1/50	65/18670	0.1602	0.3709	0.3324	ACVR2A	1
BP	GO:0071806	protein transmembrane transport	1/50	65/18670	0.1602	0.3709	0.3324	PEX10	1
BP	GO:0072577	endothelial cell apoptotic process	1/50	65/18670	0.1602	0.3709	0.3324	NFE2L2	1
BP	GO:0031334	positive regulation of protein complex assembly	2/50	268/18670	0.1611	0.3717	0.3331	ERCC2/CCR7	2
BP	GO:0031668	cellular response to extracellular stimulus	2/50	268/18670	0.1611	0.3717	0.3331	RRAGD/NFE2L2	2
BP	GO:0015800	acidic amino acid transport	1/50	66/18670	0.1625	0.3728	0.3341	RAB3A	1
BP	GO:0046888	negative regulation of hormone secretion	1/50	66/18670	0.1625	0.3728	0.3341	ADRA2B	1
BP	GO:0051785	positive regulation of nuclear division	1/50	66/18670	0.1625	0.3728	0.3341	PRDM7	1
BP	GO:0019748	secondary metabolic process	1/50	67/18670	0.1647	0.3761	0.337	NFE2L2	1
BP	GO:0003341	cilium movement	1/50	68/18670	0.167	0.3761	0.337	TTLL1	1
BP	GO:0006625	protein targeting to peroxisome	1/50	68/18670	0.167	0.3761	0.337	PEX10	1
BP	GO:0019915	lipid storage	1/50	68/18670	0.167	0.3761	0.337	C3	1
BP	GO:0031343	positive regulation of cell killing	1/50	68/18670	0.167	0.3761	0.337	CD1B	1
BP	GO:0046323	glucose import	1/50	68/18670	0.167	0.3761	0.337	NFE2L2	1
BP	GO:0071230	cellular response to amino acid stimulus	1/50	68/18670	0.167	0.3761	0.337	RRAGD	1
BP	GO:0072662	protein localization to peroxisome	1/50	68/18670	0.167	0.3761	0.337	PEX10	1
BP	GO:0072663	establishment of protein localization to peroxisome	1/50	68/18670	0.167	0.3761	0.337	PEX10	1
BP	GO:0008088	axo-dendritic transport	1/50	69/18670	0.1692	0.3761	0.337	TRIM46	1
BP	GO:0015909	long-chain fatty acid transport	1/50	69/18670	0.1692	0.3761	0.337	SLC25A20	1
BP	GO:0030166	proteoglycan biosynthetic process	1/50	69/18670	0.1692	0.3761	0.337	GAL3ST4	1
BP	GO:0036465	synaptic vesicle recycling	1/50	69/18670	0.1692	0.3761	0.337	RAB3A	1
BP	GO:0043574	peroxisomal transport	1/50	69/18670	0.1692	0.3761	0.337	PEX10	1
BP	GO:0050771	negative regulation of axonogenesis	1/50	69/18670	0.1692	0.3761	0.337	TRIM46	1
BP	GO:0070227	lymphocyte apoptotic process	1/50	69/18670	0.1692	0.3761	0.337	NOC2L	1
BP	GO:0071300	cellular response to retinoic acid	1/50	69/18670	0.1692	0.3761	0.337	LTK	1
BP	GO:2000243	positive regulation of reproductive process	1/50	69/18670	0.1692	0.3761	0.337	PRDM7	1
BP	GO:0001822	kidney development	2/50	278/18670	0.1706	0.3778	0.3385	IRX3/FRAS1	2
BP	GO:0002709	regulation of T cell mediated immunity	1/50	70/18670	0.1714	0.3778	0.3385	CD1B	1
BP	GO:0033077	T cell differentiation in thymus	1/50	70/18670	0.1714	0.3778	0.3385	CCR7	1
BP	GO:0050766	positive regulation of phagocytosis	1/50	70/18670	0.1714	0.3778	0.3385	C3	1
BP	GO:0072091	regulation of stem cell proliferation	1/50	70/18670	0.1714	0.3778	0.3385	THPO	1
BP	GO:0010976	positive regulation of neuron projection development	2/50	281/18670	0.1735	0.3814	0.3417	LTK/NFE2L2	2
BP	GO:0042273	ribosomal large subunit biogenesis	1/50	71/18670	0.1737	0.3814	0.3417	NOC2L	1
BP	GO:0007018	microtubule-based movement	2/50	283/18670	0.1754	0.3844	0.3445	TRIM46/TTLL1	2
BP	GO:1902036	regulation of hematopoietic stem cell differentiation	1/50	72/18670	0.1759	0.3849	0.3449	NFE2L2	1
BP	GO:0002312	B cell activation involved in immune response	1/50	73/18670	0.1781	0.3864	0.3463	CD180	1
BP	GO:0006283	transcription-coupled nucleotide-excision repair	1/50	73/18670	0.1781	0.3864	0.3463	ERCC2	1
BP	GO:0006801	superoxide metabolic process	1/50	73/18670	0.1781	0.3864	0.3463	NFE2L2	1
BP	GO:0009988	cell-cell recognition	1/50	73/18670	0.1781	0.3864	0.3463	CCR7	1
BP	GO:1901983	regulation of protein acetylation	1/50	73/18670	0.1781	0.3864	0.3463	NOC2L	1
BP	GO:0071824	protein-DNA complex subunit organization	2/50	288/18670	0.1802	0.3879	0.3477	TAF1B/ERCC2	2
BP	GO:0098656	anion transmembrane transport	2/50	288/18670	0.1802	0.3879	0.3477	CLCNKA/SLC25A20	2
BP	GO:0032418	lysosome localization	1/50	74/18670	0.1803	0.3879	0.3477	RAB3A	1
BP	GO:0072078	nephron tubule morphogenesis	1/50	74/18670	0.1803	0.3879	0.3477	IRX3	1
BP	GO:1903036	positive regulation of response to wounding	1/50	74/18670	0.1803	0.3879	0.3477	NFE2L2	1
BP	GO:0097193	intrinsic apoptotic signaling pathway	2/50	289/18670	0.1811	0.3888	0.3484	NOC2L/NFE2L2	2
BP	GO:0042063	gliogenesis	2/50	290/18670	0.1821	0.3888	0.3484	ERCC2/C1QA	2
BP	GO:0051650	establishment of vesicle localization	2/50	290/18670	0.1821	0.3888	0.3484	RAB3A/TRIM46	2
BP	GO:0032482	Rab protein signal transduction	1/50	75/18670	0.1825	0.3888	0.3484	RAB3A	1
BP	GO:0150076	neuroinflammatory response	1/50	75/18670	0.1825	0.3888	0.3484	C1QA	1
BP	GO:1903201	regulation of oxidative stress-induced cell death	1/50	75/18670	0.1825	0.3888	0.3484	NFE2L2	1
BP	GO:0071356	cellular response to tumor necrosis factor	2/50	291/18670	0.1831	0.3888	0.3484	TNFRSF9/NFE2L2	2
BP	GO:0006310	DNA recombination	2/50	292/18670	0.184	0.3888	0.3484	ERCC2/PRDM7	2
BP	GO:0030500	regulation of bone mineralization	1/50	76/18670	0.1847	0.3888	0.3484	ACVR2A	1
BP	GO:0042310	vasoconstriction	1/50	76/18670	0.1847	0.3888	0.3484	ADRA2B	1
BP	GO:0045454	cell redox homeostasis	1/50	76/18670	0.1847	0.3888	0.3484	NFE2L2	1
BP	GO:0061045	negative regulation of wound healing	1/50	76/18670	0.1847	0.3888	0.3484	APCS	1
BP	GO:0072088	nephron epithelium morphogenesis	1/50	76/18670	0.1847	0.3888	0.3484	IRX3	1
BP	GO:0072001	renal system development	2/50	293/18670	0.185	0.3888	0.3484	IRX3/FRAS1	2
BP	GO:0051851	modification by host of symbiont morphology or physiology	1/50	77/18670	0.1869	0.3897	0.3492	APCS	1
BP	GO:0051937	catecholamine transport	1/50	77/18670	0.1869	0.3897	0.3492	ADRA2B	1
BP	GO:0061418	regulation of transcription from RNA polymerase II promoter in response to hypoxia	1/50	77/18670	0.1869	0.3897	0.3492	NFE2L2	1
BP	GO:0090502	RNA phosphodiester bond hydrolysis, endonucleolytic	1/50	77/18670	0.1869	0.3897	0.3492	TSEN54	1
BP	GO:0050768	negative regulation of neurogenesis	2/50	295/18670	0.1869	0.3897	0.3492	IRX3/TRIM46	2
BP	GO:1903522	regulation of blood circulation	2/50	297/18670	0.1888	0.3904	0.3499	ADRA2B/DES	2
BP	GO:0001910	regulation of leukocyte mediated cytotoxicity	1/50	78/18670	0.1891	0.3904	0.3499	CD1B	1
BP	GO:0030433	ubiquitin-dependent ERAD pathway	1/50	78/18670	0.1891	0.3904	0.3499	NFE2L2	1
BP	GO:0061333	renal tubule morphogenesis	1/50	78/18670	0.1891	0.3904	0.3499	IRX3	1
BP	GO:0072028	nephron morphogenesis	1/50	78/18670	0.1891	0.3904	0.3499	IRX3	1
BP	GO:2000300	regulation of synaptic vesicle exocytosis	1/50	78/18670	0.1891	0.3904	0.3499	RAB3A	1
BP	GO:0090068	positive regulation of cell cycle process	2/50	298/18670	0.1898	0.3913	0.3506	CCND2/PRDM7	2
BP	GO:0030193	regulation of blood coagulation	1/50	79/18670	0.1913	0.3924	0.3516	NFE2L2	1
BP	GO:0043536	positive regulation of blood vessel endothelial cell migration	1/50	79/18670	0.1913	0.3924	0.3516	NFE2L2	1
BP	GO:0045652	regulation of megakaryocyte differentiation	1/50	79/18670	0.1913	0.3924	0.3516	THPO	1
BP	GO:0070372	regulation of ERK1 and ERK2 cascade	2/50	300/18670	0.1918	0.3927	0.3519	THPO/CCR7	2
BP	GO:0043462	regulation of ATPase activity	1/50	80/18670	0.1935	0.3942	0.3532	RAB3A	1
BP	GO:0140029	exocytic process	1/50	80/18670	0.1935	0.3942	0.3532	RAB3A	1
BP	GO:1900046	regulation of hemostasis	1/50	80/18670	0.1935	0.3942	0.3532	NFE2L2	1
BP	GO:0090305	nucleic acid phosphodiester bond hydrolysis	2/50	302/18670	0.1937	0.3942	0.3532	ERCC2/TSEN54	2
BP	GO:0007031	peroxisome organization	1/50	81/18670	0.1956	0.3956	0.3545	PEX10	1
BP	GO:0014032	neural crest cell development	1/50	81/18670	0.1956	0.3956	0.3545	PHACTR4	1
BP	GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process	1/50	81/18670	0.1956	0.3956	0.3545	NFE2L2	1
BP	GO:0048708	astrocyte differentiation	1/50	81/18670	0.1956	0.3956	0.3545	C1QA	1
BP	GO:0051648	vesicle localization	2/50	306/18670	0.1976	0.3974	0.3562	RAB3A/TRIM46	2
BP	GO:0034644	cellular response to UV	1/50	82/18670	0.1978	0.3974	0.3562	NOC2L	1
BP	GO:0051702	interaction with symbiont	1/50	82/18670	0.1978	0.3974	0.3562	APCS	1
BP	GO:1905954	positive regulation of lipid localization	1/50	82/18670	0.1978	0.3974	0.3562	C3	1
BP	GO:0006368	transcription elongation from RNA polymerase II promoter	1/50	84/18670	0.2021	0.4016	0.3599	ERCC2	1
BP	GO:0014910	regulation of smooth muscle cell migration	1/50	84/18670	0.2021	0.4016	0.3599	NFE2L2	1
BP	GO:0046889	positive regulation of lipid biosynthetic process	1/50	84/18670	0.2021	0.4016	0.3599	LPGAT1	1
BP	GO:0050818	regulation of coagulation	1/50	84/18670	0.2021	0.4016	0.3599	NFE2L2	1
BP	GO:0097756	negative regulation of blood vessel diameter	1/50	84/18670	0.2021	0.4016	0.3599	ADRA2B	1
BP	GO:1902803	regulation of synaptic vesicle transport	1/50	84/18670	0.2021	0.4016	0.3599	RAB3A	1
BP	GO:1905897	regulation of response to endoplasmic reticulum stress	1/50	84/18670	0.2021	0.4016	0.3599	NFE2L2	1
BP	GO:0034612	response to tumor necrosis factor	2/50	312/18670	0.2034	0.4016	0.3599	TNFRSF9/NFE2L2	2
BP	GO:0014031	mesenchymal cell development	1/50	85/18670	0.2042	0.4016	0.3599	PHACTR4	1
BP	GO:0034308	primary alcohol metabolic process	1/50	85/18670	0.2042	0.4016	0.3599	RDH8	1
BP	GO:0048864	stem cell development	1/50	85/18670	0.2042	0.4016	0.3599	PHACTR4	1
BP	GO:0072384	organelle transport along microtubule	1/50	85/18670	0.2042	0.4016	0.3599	TRIM46	1
BP	GO:1901532	regulation of hematopoietic progenitor cell differentiation	1/50	85/18670	0.2042	0.4016	0.3599	NFE2L2	1
BP	GO:1903901	negative regulation of viral life cycle	1/50	85/18670	0.2042	0.4016	0.3599	APCS	1
BP	GO:0009416	response to light stimulus	2/50	314/18670	0.2054	0.4021	0.3603	ERCC2/NOC2L	2
BP	GO:0051961	negative regulation of nervous system development	2/50	315/18670	0.2064	0.4021	0.3603	IRX3/TRIM46	2
BP	GO:0001942	hair follicle development	1/50	86/18670	0.2064	0.4021	0.3603	ERCC2	1
BP	GO:0006890	retrograde vesicle-mediated transport, Golgi to ER	1/50	86/18670	0.2064	0.4021	0.3603	COPB2	1
BP	GO:0042446	hormone biosynthetic process	1/50	86/18670	0.2064	0.4021	0.3603	RDH8	1
BP	GO:0070542	response to fatty acid	1/50	86/18670	0.2064	0.4021	0.3603	CCR7	1
BP	GO:0070371	ERK1 and ERK2 cascade	2/50	317/18670	0.2083	0.4024	0.3606	THPO/CCR7	2
BP	GO:0002690	positive regulation of leukocyte chemotaxis	1/50	87/18670	0.2085	0.4024	0.3606	CCR7	1
BP	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	1/50	87/18670	0.2085	0.4024	0.3606	PIK3R5	1
BP	GO:0030317	flagellated sperm motility	1/50	87/18670	0.2085	0.4024	0.3606	TTLL1	1
BP	GO:0097722	sperm motility	1/50	87/18670	0.2085	0.4024	0.3606	TTLL1	1
BP	GO:0006650	glycerophospholipid metabolic process	2/50	319/18670	0.2103	0.4024	0.3606	PIK3R5/LPGAT1	2
BP	GO:0022404	molting cycle process	1/50	88/18670	0.2106	0.4024	0.3606	ERCC2	1
BP	GO:0022405	hair cycle process	1/50	88/18670	0.2106	0.4024	0.3606	ERCC2	1
BP	GO:0045921	positive regulation of exocytosis	1/50	88/18670	0.2106	0.4024	0.3606	RAB3A	1
BP	GO:0098773	skin epidermis development	1/50	88/18670	0.2106	0.4024	0.3606	ERCC2	1
BP	GO:1900407	regulation of cellular response to oxidative stress	1/50	88/18670	0.2106	0.4024	0.3606	NFE2L2	1
BP	GO:1902476	chloride transmembrane transport	1/50	88/18670	0.2106	0.4024	0.3606	CLCNKA	1
BP	GO:1904035	regulation of epithelial cell apoptotic process	1/50	88/18670	0.2106	0.4024	0.3606	NFE2L2	1
BP	GO:0006470	protein dephosphorylation	2/50	321/18670	0.2123	0.4049	0.3628	PHACTR4/PPP1R12A	2
BP	GO:0060021	roof of mouth development	1/50	89/18670	0.2128	0.4051	0.363	FRAS1	1
BP	GO:0060562	epithelial tube morphogenesis	2/50	322/18670	0.2132	0.4051	0.363	IRX3/PHACTR4	2
BP	GO:0001843	neural tube closure	1/50	90/18670	0.2149	0.4051	0.363	PHACTR4	1
BP	GO:0014033	neural crest cell differentiation	1/50	90/18670	0.2149	0.4051	0.363	PHACTR4	1
BP	GO:0015844	monoamine transport	1/50	90/18670	0.2149	0.4051	0.363	ADRA2B	1
BP	GO:0032651	regulation of interleukin-1 beta production	1/50	90/18670	0.2149	0.4051	0.363	CCR7	1
BP	GO:0045778	positive regulation of ossification	1/50	90/18670	0.2149	0.4051	0.363	ACVR2A	1
BP	GO:1903035	negative regulation of response to wounding	1/50	90/18670	0.2149	0.4051	0.363	APCS	1
BP	GO:0014909	smooth muscle cell migration	1/50	91/18670	0.217	0.406	0.3639	NFE2L2	1
BP	GO:0045638	negative regulation of myeloid cell differentiation	1/50	91/18670	0.217	0.406	0.3639	APCS	1
BP	GO:0060333	interferon-gamma-mediated signaling pathway	1/50	91/18670	0.217	0.406	0.3639	OAS2	1
BP	GO:0060606	tube closure	1/50	91/18670	0.217	0.406	0.3639	PHACTR4	1
BP	GO:1901992	positive regulation of mitotic cell cycle phase transition	1/50	91/18670	0.217	0.406	0.3639	CCND2	1
BP	GO:0071103	DNA conformation change	2/50	327/18670	0.2182	0.4076	0.3653	ERCC2/NOC2L	2
BP	GO:0016485	protein processing	2/50	328/18670	0.2192	0.4089	0.3664	C1QA/C3	2
BP	GO:0001655	urogenital system development	2/50	330/18670	0.2211	0.4097	0.3672	IRX3/FRAS1	2
BP	GO:0051235	maintenance of location	2/50	330/18670	0.2211	0.4097	0.3672	C3/CCR7	2
BP	GO:0007589	body fluid secretion	1/50	93/18670	0.2212	0.4097	0.3672	OAS2	1
BP	GO:0036473	cell death in response to oxidative stress	1/50	93/18670	0.2212	0.4097	0.3672	NFE2L2	1
BP	GO:0072080	nephron tubule development	1/50	93/18670	0.2212	0.4097	0.3672	IRX3	1
BP	GO:0006029	proteoglycan metabolic process	1/50	94/18670	0.2233	0.4098	0.3672	GAL3ST4	1
BP	GO:0006906	vesicle fusion	1/50	94/18670	0.2233	0.4098	0.3672	RAB3A	1
BP	GO:0070167	regulation of biomineral tissue development	1/50	94/18670	0.2233	0.4098	0.3672	ACVR2A	1
BP	GO:1901216	positive regulation of neuron death	1/50	94/18670	0.2233	0.4098	0.3672	C1QA	1
BP	GO:0015849	organic acid transport	2/50	333/18670	0.2241	0.4098	0.3672	RAB3A/SLC25A20	2
BP	GO:0046942	carboxylic acid transport	2/50	333/18670	0.2241	0.4098	0.3672	RAB3A/SLC25A20	2
BP	GO:0042100	B cell proliferation	1/50	95/18670	0.2254	0.4098	0.3672	CD180	1
BP	GO:0042116	macrophage activation	1/50	95/18670	0.2254	0.4098	0.3672	C1QA	1
BP	GO:0051952	regulation of amine transport	1/50	95/18670	0.2254	0.4098	0.3672	ADRA2B	1
BP	GO:0060337	type I interferon signaling pathway	1/50	95/18670	0.2254	0.4098	0.3672	OAS2	1
BP	GO:0061326	renal tubule development	1/50	95/18670	0.2254	0.4098	0.3672	IRX3	1
BP	GO:0071357	cellular response to type I interferon	1/50	95/18670	0.2254	0.4098	0.3672	OAS2	1
BP	GO:2000060	positive regulation of ubiquitin-dependent protein catabolic process	1/50	95/18670	0.2254	0.4098	0.3672	NFE2L2	1
BP	GO:0006835	dicarboxylic acid transport	1/50	96/18670	0.2275	0.4109	0.3682	RAB3A	1
BP	GO:0019217	regulation of fatty acid metabolic process	1/50	96/18670	0.2275	0.4109	0.3682	LPGAT1	1
BP	GO:0030219	megakaryocyte differentiation	1/50	96/18670	0.2275	0.4109	0.3682	THPO	1
BP	GO:0030516	regulation of axon extension	1/50	96/18670	0.2275	0.4109	0.3682	TRIM46	1
BP	GO:0043405	regulation of MAP kinase activity	2/50	337/18670	0.228	0.4109	0.3682	PIK3R5/ADRA2B	2
BP	GO:0010771	negative regulation of cell morphogenesis involved in differentiation	1/50	97/18670	0.2296	0.4109	0.3682	TRIM46	1
BP	GO:0014020	primary neural tube formation	1/50	97/18670	0.2296	0.4109	0.3682	PHACTR4	1
BP	GO:0015908	fatty acid transport	1/50	97/18670	0.2296	0.4109	0.3682	SLC25A20	1
BP	GO:0048709	oligodendrocyte differentiation	1/50	97/18670	0.2296	0.4109	0.3682	ERCC2	1
BP	GO:0090630	activation of GTPase activity	1/50	97/18670	0.2296	0.4109	0.3682	CCR7	1
BP	GO:1902882	regulation of response to oxidative stress	1/50	97/18670	0.2296	0.4109	0.3682	NFE2L2	1
BP	GO:0071496	cellular response to external stimulus	2/50	339/18670	0.23	0.4111	0.3684	RRAGD/NFE2L2	2
BP	GO:0031341	regulation of cell killing	1/50	98/18670	0.2316	0.4129	0.37	CD1B	1
BP	GO:0050764	regulation of phagocytosis	1/50	98/18670	0.2316	0.4129	0.37	C3	1
BP	GO:0030838	positive regulation of actin filament polymerization	1/50	99/18670	0.2337	0.4142	0.3712	CCR7	1
BP	GO:0034340	response to type I interferon	1/50	99/18670	0.2337	0.4142	0.3712	OAS2	1
BP	GO:0048525	negative regulation of viral process	1/50	99/18670	0.2337	0.4142	0.3712	APCS	1
BP	GO:0070301	cellular response to hydrogen peroxide	1/50	99/18670	0.2337	0.4142	0.3712	NFE2L2	1
BP	GO:0010721	negative regulation of cell development	2/50	344/18670	0.235	0.4145	0.3714	IRX3/TRIM46	2
BP	GO:0035282	segmentation	1/50	100/18670	0.2358	0.4145	0.3714	IRX3	1
BP	GO:0036503	ERAD pathway	1/50	100/18670	0.2358	0.4145	0.3714	NFE2L2	1
BP	GO:0060840	artery development	1/50	100/18670	0.2358	0.4145	0.3714	LOXL1	1
BP	GO:0090174	organelle membrane fusion	1/50	100/18670	0.2358	0.4145	0.3714	RAB3A	1
BP	GO:2001023	regulation of response to drug	1/50	100/18670	0.2358	0.4145	0.3714	NFE2L2	1
BP	GO:0031532	actin cytoskeleton reorganization	1/50	101/18670	0.2378	0.4158	0.3726	PLEK2	1
BP	GO:0032611	interleukin-1 beta production	1/50	101/18670	0.2378	0.4158	0.3726	CCR7	1
BP	GO:0032649	regulation of interferon-gamma production	1/50	101/18670	0.2378	0.4158	0.3726	CCR7	1
BP	GO:1990542	mitochondrial transmembrane transport	1/50	101/18670	0.2378	0.4158	0.3726	SLC25A20	1
BP	GO:0009101	glycoprotein biosynthetic process	2/50	348/18670	0.2389	0.4165	0.3733	GAL3ST4/CCR7	2
BP	GO:0000079	regulation of cyclin-dependent protein serine/threonine kinase activity	1/50	102/18670	0.2399	0.4165	0.3733	CCND2	1
BP	GO:0015837	amine transport	1/50	102/18670	0.2399	0.4165	0.3733	ADRA2B	1
BP	GO:0098869	cellular oxidant detoxification	1/50	102/18670	0.2399	0.4165	0.3733	NFE2L2	1
BP	GO:2000379	positive regulation of reactive oxygen species metabolic process	1/50	102/18670	0.2399	0.4165	0.3733	NFE2L2	1
BP	GO:0007229	integrin-mediated signaling pathway	1/50	103/18670	0.2419	0.4174	0.374	PHACTR4	1
BP	GO:0032652	regulation of interleukin-1 production	1/50	103/18670	0.2419	0.4174	0.374	CCR7	1
BP	GO:0048259	regulation of receptor-mediated endocytosis	1/50	103/18670	0.2419	0.4174	0.374	C3	1
BP	GO:1902106	negative regulation of leukocyte differentiation	1/50	103/18670	0.2419	0.4174	0.374	APCS	1
BP	GO:0001523	retinoid metabolic process	1/50	104/18670	0.244	0.4174	0.374	RDH8	1
BP	GO:0014812	muscle cell migration	1/50	104/18670	0.244	0.4174	0.374	NFE2L2	1
BP	GO:0030593	neutrophil chemotaxis	1/50	104/18670	0.244	0.4174	0.374	CCR7	1
BP	GO:0046822	regulation of nucleocytoplasmic transport	1/50	104/18670	0.244	0.4174	0.374	PPP1R12A	1
BP	GO:0046928	regulation of neurotransmitter secretion	1/50	104/18670	0.244	0.4174	0.374	RAB3A	1
BP	GO:0090100	positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	1/50	104/18670	0.244	0.4174	0.374	ACVR2A	1
BP	GO:1901800	positive regulation of proteasomal protein catabolic process	1/50	104/18670	0.244	0.4174	0.374	NFE2L2	1
BP	GO:0001841	neural tube formation	1/50	105/18670	0.246	0.4175	0.3742	PHACTR4	1
BP	GO:0006637	acyl-CoA metabolic process	1/50	105/18670	0.246	0.4175	0.3742	ACSF2	1
BP	GO:0006641	triglyceride metabolic process	1/50	105/18670	0.246	0.4175	0.3742	C3	1
BP	GO:0007009	plasma membrane organization	1/50	105/18670	0.246	0.4175	0.3742	RAB3A	1
BP	GO:0032006	regulation of TOR signaling	1/50	105/18670	0.246	0.4175	0.3742	RRAGD	1
BP	GO:0035383	thioester metabolic process	1/50	105/18670	0.246	0.4175	0.3742	ACSF2	1
BP	GO:0002456	T cell mediated immunity	1/50	106/18670	0.248	0.4187	0.3752	CD1B	1
BP	GO:0021510	spinal cord development	1/50	106/18670	0.248	0.4187	0.3752	ERCC2	1
BP	GO:1901989	positive regulation of cell cycle phase transition	1/50	106/18670	0.248	0.4187	0.3752	CCND2	1
BP	GO:1904029	regulation of cyclin-dependent protein kinase activity	1/50	106/18670	0.248	0.4187	0.3752	CCND2	1
BP	GO:0001666	response to hypoxia	2/50	359/18670	0.2499	0.4199	0.3763	ERCC2/NFE2L2	2
BP	GO:0001909	leukocyte mediated cytotoxicity	1/50	107/18670	0.2501	0.4199	0.3763	CD1B	1
BP	GO:0051341	regulation of oxidoreductase activity	1/50	107/18670	0.2501	0.4199	0.3763	ACVR2A	1
BP	GO:0098781	ncRNA transcription	1/50	107/18670	0.2501	0.4199	0.3763	TAF1B	1
BP	GO:0006936	muscle contraction	2/50	360/18670	0.2509	0.4208	0.3771	ADRA2B/DES	2
BP	GO:0006821	chloride transport	1/50	108/18670	0.2521	0.4211	0.3774	CLCNKA	1
BP	GO:0015696	ammonium transport	1/50	108/18670	0.2521	0.4211	0.3774	SLC25A20	1
BP	GO:0032526	response to retinoic acid	1/50	108/18670	0.2521	0.4211	0.3774	LTK	1
BP	GO:0045862	positive regulation of proteolysis	2/50	363/18670	0.2539	0.4224	0.3785	C3/NFE2L2	2
BP	GO:0006289	nucleotide-excision repair	1/50	109/18670	0.2541	0.4224	0.3785	ERCC2	1
BP	GO:0072009	nephron epithelium development	1/50	109/18670	0.2541	0.4224	0.3785	IRX3	1
BP	GO:0010038	response to metal ion	2/50	364/18670	0.2549	0.4224	0.3785	C1QA/NFE2L2	2
BP	GO:0006664	glycolipid metabolic process	1/50	110/18670	0.2561	0.4224	0.3785	GAL3ST4	1
BP	GO:0006939	smooth muscle contraction	1/50	110/18670	0.2561	0.4224	0.3785	ADRA2B	1
BP	GO:0016101	diterpenoid metabolic process	1/50	110/18670	0.2561	0.4224	0.3785	RDH8	1
BP	GO:0032508	DNA duplex unwinding	1/50	110/18670	0.2561	0.4224	0.3785	ERCC2	1
BP	GO:0061387	regulation of extent of cell growth	1/50	110/18670	0.2561	0.4224	0.3785	TRIM46	1
BP	GO:0072676	lymphocyte migration	1/50	111/18670	0.2581	0.4224	0.3785	CCR7	1
BP	GO:0098661	inorganic anion transmembrane transport	1/50	111/18670	0.2581	0.4224	0.3785	CLCNKA	1
BP	GO:1903509	liposaccharide metabolic process	1/50	111/18670	0.2581	0.4224	0.3785	GAL3ST4	1
BP	GO:1904019	epithelial cell apoptotic process	1/50	111/18670	0.2581	0.4224	0.3785	NFE2L2	1
BP	GO:0006909	phagocytosis	2/50	369/18670	0.2598	0.4224	0.3785	CD302/C3	2
BP	GO:0035690	cellular response to drug	2/50	369/18670	0.2598	0.4224	0.3785	PPP1R12A/NFE2L2	2
BP	GO:0017158	regulation of calcium ion-dependent exocytosis	1/50	112/18670	0.2601	0.4224	0.3785	RAB3A	1
BP	GO:0042303	molting cycle	1/50	112/18670	0.2601	0.4224	0.3785	ERCC2	1
BP	GO:0042633	hair cycle	1/50	112/18670	0.2601	0.4224	0.3785	ERCC2	1
BP	GO:0048593	camera-type eye morphogenesis	1/50	112/18670	0.2601	0.4224	0.3785	PHACTR4	1
BP	GO:0051817	modification of morphology or physiology of other organism involved in symbiotic interaction	1/50	112/18670	0.2601	0.4224	0.3785	APCS	1
BP	GO:0098693	regulation of synaptic vesicle cycle	1/50	112/18670	0.2601	0.4224	0.3785	RAB3A	1
BP	GO:1990748	cellular detoxification	1/50	112/18670	0.2601	0.4224	0.3785	NFE2L2	1
BP	GO:0032535	regulation of cellular component size	2/50	370/18670	0.2608	0.4225	0.3786	TRIM46/CCR7	2
BP	GO:0036293	response to decreased oxygen levels	2/50	370/18670	0.2608	0.4225	0.3786	ERCC2/NFE2L2	2
BP	GO:0032609	interferon-gamma production	1/50	113/18670	0.2621	0.4229	0.379	CCR7	1
BP	GO:0043200	response to amino acid	1/50	113/18670	0.2621	0.4229	0.379	RRAGD	1
BP	GO:0048640	negative regulation of developmental growth	1/50	113/18670	0.2621	0.4229	0.379	TRIM46	1
BP	GO:0001701	in utero embryonic development	2/50	373/18670	0.2638	0.424	0.38	ERCC2/SLC25A20	2
BP	GO:0002688	regulation of leukocyte chemotaxis	1/50	114/18670	0.2641	0.424	0.38	CCR7	1
BP	GO:0007127	meiosis I	1/50	114/18670	0.2641	0.424	0.38	PRDM7	1
BP	GO:0034968	histone lysine methylation	1/50	114/18670	0.2641	0.424	0.38	PRDM7	1
BP	GO:0010927	cellular component assembly involved in morphogenesis	1/50	115/18670	0.2661	0.4261	0.3819	ERCC2	1
BP	GO:0032612	interleukin-1 production	1/50	115/18670	0.2661	0.4261	0.3819	CCR7	1
BP	GO:0006661	phosphatidylinositol biosynthetic process	1/50	116/18670	0.268	0.4277	0.3833	PIK3R5	1
BP	GO:0070252	actin-mediated cell contraction	1/50	116/18670	0.268	0.4277	0.3833	DES	1
BP	GO:2000736	regulation of stem cell differentiation	1/50	116/18670	0.268	0.4277	0.3833	NFE2L2	1
BP	GO:0002761	regulation of myeloid leukocyte differentiation	1/50	117/18670	0.27	0.4303	0.3856	APCS	1
BP	GO:0006911	phagocytosis, engulfment	1/50	118/18670	0.272	0.4317	0.3869	C3	1
BP	GO:1990266	neutrophil migration	1/50	118/18670	0.272	0.4317	0.3869	CCR7	1
BP	GO:0045765	regulation of angiogenesis	2/50	383/18670	0.2738	0.4317	0.3869	C3/NFE2L2	2
BP	GO:0001952	regulation of cell-matrix adhesion	1/50	119/18670	0.2739	0.4317	0.3869	CCR7	1
BP	GO:0007368	determination of left/right symmetry	1/50	119/18670	0.2739	0.4317	0.3869	ACVR2A	1
BP	GO:0016079	synaptic vesicle exocytosis	1/50	119/18670	0.2739	0.4317	0.3869	RAB3A	1
BP	GO:0032392	DNA geometric change	1/50	119/18670	0.2739	0.4317	0.3869	ERCC2	1
BP	GO:0051193	regulation of cofactor metabolic process	1/50	119/18670	0.2739	0.4317	0.3869	NFE2L2	1
BP	GO:0061982	meiosis I cell cycle process	1/50	119/18670	0.2739	0.4317	0.3869	PRDM7	1
BP	GO:0006721	terpenoid metabolic process	1/50	120/18670	0.2759	0.4332	0.3882	RDH8	1
BP	GO:0072089	stem cell proliferation	1/50	120/18670	0.2759	0.4332	0.3882	THPO	1
BP	GO:1903052	positive regulation of proteolysis involved in cellular protein catabolic process	1/50	120/18670	0.2759	0.4332	0.3882	NFE2L2	1
BP	GO:0010811	positive regulation of cell-substrate adhesion	1/50	121/18670	0.2779	0.4336	0.3885	CCR7	1
BP	GO:0030968	endoplasmic reticulum unfolded protein response	1/50	121/18670	0.2779	0.4336	0.3885	NFE2L2	1
BP	GO:0043618	regulation of transcription from RNA polymerase II promoter in response to stress	1/50	121/18670	0.2779	0.4336	0.3885	NFE2L2	1
BP	GO:0046718	viral entry into host cell	1/50	121/18670	0.2779	0.4336	0.3885	APCS	1
BP	GO:0048675	axon extension	1/50	121/18670	0.2779	0.4336	0.3885	TRIM46	1
BP	GO:0045787	positive regulation of cell cycle	2/50	389/18670	0.2798	0.4356	0.3903	CCND2/PRDM7	2
BP	GO:0032434	regulation of proteasomal ubiquitin-dependent protein catabolic process	1/50	122/18670	0.2798	0.4356	0.3903	NFE2L2	1
BP	GO:0071621	granulocyte chemotaxis	1/50	123/18670	0.2817	0.4379	0.3924	CCR7	1
BP	GO:0007098	centrosome cycle	1/50	124/18670	0.2837	0.4379	0.3924	PPP1R12A	1
BP	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	1/50	124/18670	0.2837	0.4379	0.3924	PIK3R5	1
BP	GO:0046717	acid secretion	1/50	124/18670	0.2837	0.4379	0.3924	RAB3A	1
BP	GO:0048284	organelle fusion	1/50	124/18670	0.2837	0.4379	0.3924	RAB3A	1
BP	GO:0051101	regulation of DNA binding	1/50	124/18670	0.2837	0.4379	0.3924	ERCC2	1
BP	GO:0051209	release of sequestered calcium ion into cytosol	1/50	124/18670	0.2837	0.4379	0.3924	CCR7	1
BP	GO:0070482	response to oxygen levels	2/50	394/18670	0.2847	0.4387	0.3932	ERCC2/NFE2L2	2
BP	GO:0030326	embryonic limb morphogenesis	1/50	125/18670	0.2856	0.4387	0.3932	FRAS1	1
BP	GO:0031929	TOR signaling	1/50	125/18670	0.2856	0.4387	0.3932	RRAGD	1
BP	GO:0035113	embryonic appendage morphogenesis	1/50	125/18670	0.2856	0.4387	0.3932	FRAS1	1
BP	GO:0045667	regulation of osteoblast differentiation	1/50	126/18670	0.2875	0.4399	0.3942	ACVR2A	1
BP	GO:0048706	embryonic skeletal system development	1/50	126/18670	0.2875	0.4399	0.3942	ACVR2A	1
BP	GO:0051283	negative regulation of sequestering of calcium ion	1/50	126/18670	0.2875	0.4399	0.3942	CCR7	1
BP	GO:0051604	protein maturation	2/50	397/18670	0.2877	0.4399	0.3942	C1QA/C3	2
BP	GO:0001503	ossification	2/50	398/18670	0.2887	0.4409	0.3951	ACVR2A/ERCC2	2
BP	GO:0043620	regulation of DNA-templated transcription in response to stress	1/50	127/18670	0.2895	0.4409	0.3951	NFE2L2	1
BP	GO:0099024	plasma membrane invagination	1/50	127/18670	0.2895	0.4409	0.3951	C3	1
BP	GO:0010876	lipid localization	2/50	400/18670	0.2907	0.4412	0.3954	C3/SLC25A20	2
BP	GO:0002687	positive regulation of leukocyte migration	1/50	128/18670	0.2914	0.4412	0.3954	CCR7	1
BP	GO:0009855	determination of bilateral symmetry	1/50	128/18670	0.2914	0.4412	0.3954	ACVR2A	1
BP	GO:0010595	positive regulation of endothelial cell migration	1/50	128/18670	0.2914	0.4412	0.3954	NFE2L2	1
BP	GO:0051282	regulation of sequestering of calcium ion	1/50	128/18670	0.2914	0.4412	0.3954	CCR7	1
BP	GO:0006639	acylglycerol metabolic process	1/50	129/18670	0.2933	0.4415	0.3956	C3	1
BP	GO:0009799	specification of symmetry	1/50	129/18670	0.2933	0.4415	0.3956	ACVR2A	1
BP	GO:0018022	peptidyl-lysine methylation	1/50	129/18670	0.2933	0.4415	0.3956	PRDM7	1
BP	GO:0034754	cellular hormone metabolic process	1/50	129/18670	0.2933	0.4415	0.3956	RDH8	1
BP	GO:0071482	cellular response to light stimulus	1/50	129/18670	0.2933	0.4415	0.3956	NOC2L	1
BP	GO:0006638	neutral lipid metabolic process	1/50	130/18670	0.2952	0.4433	0.3973	C3	1
BP	GO:0008033	tRNA processing	1/50	130/18670	0.2952	0.4433	0.3973	TSEN54	1
BP	GO:0043900	regulation of multi-organism process	2/50	405/18670	0.2957	0.4435	0.3975	APCS/CD180	2
BP	GO:2001233	regulation of apoptotic signaling pathway	2/50	406/18670	0.2967	0.4441	0.398	NOC2L/NFE2L2	2
BP	GO:0051208	sequestering of calcium ion	1/50	131/18670	0.2971	0.4441	0.398	CCR7	1
BP	GO:0098754	detoxification	1/50	131/18670	0.2971	0.4441	0.398	NFE2L2	1
BP	GO:0042552	myelination	1/50	132/18670	0.299	0.4459	0.3996	ERCC2	1
BP	GO:0045995	regulation of embryonic development	1/50	132/18670	0.299	0.4459	0.3996	NFE2L2	1
BP	GO:0031023	microtubule organizing center organization	1/50	133/18670	0.3009	0.4473	0.4009	PPP1R12A	1
BP	GO:0007272	ensheathment of neurons	1/50	134/18670	0.3028	0.4473	0.4009	ERCC2	1
BP	GO:0008366	axon ensheathment	1/50	134/18670	0.3028	0.4473	0.4009	ERCC2	1
BP	GO:0030260	entry into host cell	1/50	134/18670	0.3028	0.4473	0.4009	APCS	1
BP	GO:0032273	positive regulation of protein polymerization	1/50	134/18670	0.3028	0.4473	0.4009	CCR7	1
BP	GO:0044409	entry into host	1/50	134/18670	0.3028	0.4473	0.4009	APCS	1
BP	GO:0051806	entry into cell of other organism involved in symbiotic interaction	1/50	134/18670	0.3028	0.4473	0.4009	APCS	1
BP	GO:0051828	entry into other organism involved in symbiotic interaction	1/50	134/18670	0.3028	0.4473	0.4009	APCS	1
BP	GO:0010324	membrane invagination	1/50	135/18670	0.3046	0.4475	0.401	C3	1
BP	GO:0030010	establishment of cell polarity	1/50	135/18670	0.3046	0.4475	0.401	CCR7	1
BP	GO:0050921	positive regulation of chemotaxis	1/50	135/18670	0.3046	0.4475	0.401	CCR7	1
BP	GO:1903825	organic acid transmembrane transport	1/50	135/18670	0.3046	0.4475	0.401	SLC25A20	1
BP	GO:1905039	carboxylic acid transmembrane transport	1/50	135/18670	0.3046	0.4475	0.401	SLC25A20	1
BP	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process	2/50	419/18670	0.3096	0.4514	0.4045	SPSB2/NFE2L2	2
BP	GO:0043588	skin development	2/50	419/18670	0.3096	0.4514	0.4045	FRAS1/ERCC2	2
BP	GO:0008584	male gonad development	1/50	138/18670	0.3103	0.4514	0.4045	ACVR2A	1
BP	GO:0030048	actin filament-based movement	1/50	138/18670	0.3103	0.4514	0.4045	DES	1
BP	GO:0002831	regulation of response to biotic stimulus	1/50	139/18670	0.3121	0.4514	0.4045	CD180	1
BP	GO:0006720	isoprenoid metabolic process	1/50	139/18670	0.3121	0.4514	0.4045	RDH8	1
BP	GO:0007189	adenylate cyclase-activating G protein-coupled receptor signaling pathway	1/50	139/18670	0.3121	0.4514	0.4045	ADRA2B	1
BP	GO:0016571	histone methylation	1/50	139/18670	0.3121	0.4514	0.4045	PRDM7	1
BP	GO:0046546	development of primary male sexual characteristics	1/50	139/18670	0.3121	0.4514	0.4045	ACVR2A	1
BP	GO:0051588	regulation of neurotransmitter transport	1/50	139/18670	0.3121	0.4514	0.4045	RAB3A	1
BP	GO:1901342	regulation of vasculature development	2/50	422/18670	0.3126	0.4514	0.4045	C3/NFE2L2	2
BP	GO:0033865	nucleoside bisphosphate metabolic process	1/50	140/18670	0.314	0.4514	0.4045	ACSF2	1
BP	GO:0033875	ribonucleoside bisphosphate metabolic process	1/50	140/18670	0.314	0.4514	0.4045	ACSF2	1
BP	GO:0034032	purine nucleoside bisphosphate metabolic process	1/50	140/18670	0.314	0.4514	0.4045	ACSF2	1
BP	GO:0034620	cellular response to unfolded protein	1/50	140/18670	0.314	0.4514	0.4045	NFE2L2	1
BP	GO:0046330	positive regulation of JNK cascade	1/50	140/18670	0.314	0.4514	0.4045	CCR7	1
BP	GO:0072073	kidney epithelium development	1/50	140/18670	0.314	0.4514	0.4045	IRX3	1
BP	GO:0097553	calcium ion transmembrane import into cytosol	1/50	140/18670	0.314	0.4514	0.4045	CCR7	1
BP	GO:1903364	positive regulation of cellular protein catabolic process	1/50	140/18670	0.314	0.4514	0.4045	NFE2L2	1
BP	GO:0097530	granulocyte migration	1/50	141/18670	0.3158	0.4535	0.4064	CCR7	1
BP	GO:0046467	membrane lipid biosynthetic process	1/50	142/18670	0.3177	0.4542	0.407	GAL3ST4	1
BP	GO:0072006	nephron development	1/50	142/18670	0.3177	0.4542	0.407	IRX3	1
BP	GO:0048568	embryonic organ development	2/50	428/18670	0.3185	0.4542	0.407	PHACTR4/ERCC2	2
BP	GO:0051052	regulation of DNA metabolic process	2/50	429/18670	0.3195	0.4542	0.407	ERCC2/PRDM7	2
BP	GO:0030879	mammary gland development	1/50	143/18670	0.3195	0.4542	0.407	OAS2	1
BP	GO:0031056	regulation of histone modification	1/50	143/18670	0.3195	0.4542	0.407	NOC2L	1
BP	GO:0035296	regulation of tube diameter	1/50	143/18670	0.3195	0.4542	0.407	ADRA2B	1
BP	GO:0050880	regulation of blood vessel size	1/50	143/18670	0.3195	0.4542	0.407	ADRA2B	1
BP	GO:0097746	regulation of blood vessel diameter	1/50	143/18670	0.3195	0.4542	0.407	ADRA2B	1
BP	GO:0035150	regulation of tube size	1/50	144/18670	0.3214	0.4563	0.4089	ADRA2B	1
BP	GO:0006865	amino acid transport	1/50	145/18670	0.3232	0.4584	0.4108	RAB3A	1
BP	GO:0035264	multicellular organism growth	1/50	146/18670	0.325	0.459	0.4113	ERCC2	1
BP	GO:0042542	response to hydrogen peroxide	1/50	146/18670	0.325	0.459	0.4113	NFE2L2	1
BP	GO:2000241	regulation of reproductive process	1/50	146/18670	0.325	0.459	0.4113	PRDM7	1
BP	GO:2001251	negative regulation of chromosome organization	1/50	146/18670	0.325	0.459	0.4113	NOC2L	1
BP	GO:0071236	cellular response to antibiotic	1/50	147/18670	0.3268	0.461	0.4131	NFE2L2	1
BP	GO:0035107	appendage morphogenesis	1/50	148/18670	0.3286	0.4626	0.4145	FRAS1	1
BP	GO:0035108	limb morphogenesis	1/50	148/18670	0.3286	0.4626	0.4145	FRAS1	1
BP	GO:0019932	second-messenger-mediated signaling	2/50	439/18670	0.3294	0.4626	0.4145	ADRA2B/CCR7	2
BP	GO:0008277	regulation of G protein-coupled receptor signaling pathway	1/50	149/18670	0.3305	0.4626	0.4145	C3	1
BP	GO:0048592	eye morphogenesis	1/50	149/18670	0.3305	0.4626	0.4145	PHACTR4	1
BP	GO:1903900	regulation of viral life cycle	1/50	149/18670	0.3305	0.4626	0.4145	APCS	1
BP	GO:2000058	regulation of ubiquitin-dependent protein catabolic process	1/50	149/18670	0.3305	0.4626	0.4145	NFE2L2	1
BP	GO:0007338	single fertilization	1/50	150/18670	0.3323	0.4646	0.4163	RAB3A	1
BP	GO:1901990	regulation of mitotic cell cycle phase transition	2/50	444/18670	0.3343	0.4669	0.4184	ERCC2/CCND2	2
BP	GO:0000187	activation of MAPK activity	1/50	152/18670	0.3359	0.4681	0.4195	ADRA2B	1
BP	GO:0007286	spermatid development	1/50	152/18670	0.3359	0.4681	0.4195	TTLL1	1
BP	GO:0034250	positive regulation of cellular amide metabolic process	1/50	153/18670	0.3377	0.4689	0.4202	NFE2L2	1
BP	GO:0045807	positive regulation of endocytosis	1/50	153/18670	0.3377	0.4689	0.4202	C3	1
BP	GO:0062013	positive regulation of small molecule metabolic process	1/50	153/18670	0.3377	0.4689	0.4202	LPGAT1	1
BP	GO:0007265	Ras protein signal transduction	2/50	448/18670	0.3382	0.4689	0.4202	RAB3A/PHACTR4	2
BP	GO:0009314	response to radiation	2/50	448/18670	0.3382	0.4689	0.4202	ERCC2/NOC2L	2
BP	GO:0017156	calcium ion regulated exocytosis	1/50	154/18670	0.3395	0.469	0.4203	RAB3A	1
BP	GO:0061025	membrane fusion	1/50	154/18670	0.3395	0.469	0.4203	RAB3A	1
BP	GO:0090501	RNA phosphodiester bond hydrolysis	1/50	154/18670	0.3395	0.469	0.4203	TSEN54	1
BP	GO:0010977	negative regulation of neuron projection development	1/50	155/18670	0.3412	0.4709	0.422	TRIM46	1
BP	GO:0016573	histone acetylation	1/50	156/18670	0.343	0.4724	0.4233	NOC2L	1
BP	GO:0043535	regulation of blood vessel endothelial cell migration	1/50	156/18670	0.343	0.4724	0.4233	NFE2L2	1
BP	GO:0016570	histone modification	2/50	454/18670	0.3441	0.4733	0.4241	NOC2L/PRDM7	2
BP	GO:0030509	BMP signaling pathway	1/50	157/18670	0.3448	0.4733	0.4241	ACVR2A	1
BP	GO:1905952	regulation of lipid localization	1/50	157/18670	0.3448	0.4733	0.4241	C3	1
BP	GO:0016482	cytosolic transport	1/50	158/18670	0.3466	0.4742	0.4249	TRIM46	1
BP	GO:0048515	spermatid differentiation	1/50	158/18670	0.3466	0.4742	0.4249	TTLL1	1
BP	GO:0060402	calcium ion transport into cytosol	1/50	158/18670	0.3466	0.4742	0.4249	CCR7	1
BP	GO:0021915	neural tube development	1/50	160/18670	0.3501	0.477	0.4275	PHACTR4	1
BP	GO:0046661	male sex differentiation	1/50	160/18670	0.3501	0.477	0.4275	ACVR2A	1
BP	GO:1903305	regulation of regulated secretory pathway	1/50	160/18670	0.3501	0.477	0.4275	RAB3A	1
BP	GO:0001667	ameboidal-type cell migration	2/50	461/18670	0.351	0.477	0.4275	PHACTR4/NFE2L2	2
BP	GO:0010970	transport along microtubule	1/50	161/18670	0.3518	0.477	0.4275	TRIM46	1
BP	GO:0018393	internal peptidyl-lysine acetylation	1/50	161/18670	0.3518	0.477	0.4275	NOC2L	1
BP	GO:0035967	cellular response to topologically incorrect protein	1/50	161/18670	0.3518	0.477	0.4275	NFE2L2	1
BP	GO:0099111	microtubule-based transport	1/50	161/18670	0.3518	0.477	0.4275	TRIM46	1
BP	GO:0023061	signal release	2/50	462/18670	0.352	0.477	0.4275	RAB3A/ADRA2B	2
BP	GO:0002683	negative regulation of immune system process	2/50	463/18670	0.3529	0.4776	0.428	APCS/NFE2L2	2
BP	GO:0015718	monocarboxylic acid transport	1/50	162/18670	0.3536	0.4776	0.428	SLC25A20	1
BP	GO:0030833	regulation of actin filament polymerization	1/50	162/18670	0.3536	0.4776	0.428	CCR7	1
BP	GO:0001819	positive regulation of cytokine production	2/50	464/18670	0.3539	0.4776	0.428	C3/CCR7	2
BP	GO:0003012	muscle system process	2/50	465/18670	0.3549	0.4784	0.4287	ADRA2B/DES	2
BP	GO:0045931	positive regulation of mitotic cell cycle	1/50	163/18670	0.3553	0.4785	0.4288	CCND2	1
BP	GO:0051346	negative regulation of hydrolase activity	2/50	466/18670	0.3559	0.4787	0.429	APCS/C3	2
BP	GO:0006633	fatty acid biosynthetic process	1/50	164/18670	0.3571	0.4794	0.4296	LPGAT1	1
BP	GO:0035821	modification of morphology or physiology of other organism	1/50	164/18670	0.3571	0.4794	0.4296	APCS	1
BP	GO:0007409	axonogenesis	2/50	468/18670	0.3578	0.4798	0.43	RAB3A/TRIM46	2
BP	GO:0031497	chromatin assembly	1/50	165/18670	0.3588	0.4802	0.4303	NOC2L	1
BP	GO:0050954	sensory perception of mechanical stimulus	1/50	165/18670	0.3588	0.4802	0.4303	RAB3A	1
BP	GO:0006475	internal protein amino acid acetylation	1/50	166/18670	0.3605	0.4815	0.4315	NOC2L	1
BP	GO:0097696	STAT cascade	1/50	166/18670	0.3605	0.4815	0.4315	THPO	1
BP	GO:0033209	tumor necrosis factor-mediated signaling pathway	1/50	167/18670	0.3623	0.4833	0.4331	TNFRSF9	1
BP	GO:0016569	covalent chromatin modification	2/50	474/18670	0.3636	0.4833	0.4331	NOC2L/PRDM7	2
BP	GO:0034614	cellular response to reactive oxygen species	1/50	168/18670	0.364	0.4833	0.4331	NFE2L2	1
BP	GO:1990138	neuron projection extension	1/50	168/18670	0.364	0.4833	0.4331	TRIM46	1
BP	GO:0007269	neurotransmitter secretion	1/50	169/18670	0.3657	0.4833	0.4331	RAB3A	1
BP	GO:0015698	inorganic anion transport	1/50	169/18670	0.3657	0.4833	0.4331	CLCNKA	1
BP	GO:0018394	peptidyl-lysine acetylation	1/50	169/18670	0.3657	0.4833	0.4331	NOC2L	1
BP	GO:0050728	negative regulation of inflammatory response	1/50	169/18670	0.3657	0.4833	0.4331	APCS	1
BP	GO:0140056	organelle localization by membrane tethering	1/50	169/18670	0.3657	0.4833	0.4331	RAB3A	1
BP	GO:0010498	proteasomal protein catabolic process	2/50	477/18670	0.3666	0.4833	0.4331	SPSB2/NFE2L2	2
BP	GO:0071772	response to BMP	1/50	170/18670	0.3674	0.4833	0.4331	ACVR2A	1
BP	GO:0071773	cellular response to BMP stimulus	1/50	170/18670	0.3674	0.4833	0.4331	ACVR2A	1
BP	GO:0099643	signal release from synapse	1/50	170/18670	0.3674	0.4833	0.4331	RAB3A	1
BP	GO:0016311	dephosphorylation	2/50	478/18670	0.3675	0.4833	0.4331	PHACTR4/PPP1R12A	2
BP	GO:0006937	regulation of muscle contraction	1/50	171/18670	0.3691	0.4833	0.4331	ADRA2B	1
BP	GO:0010634	positive regulation of epithelial cell migration	1/50	171/18670	0.3691	0.4833	0.4331	NFE2L2	1
BP	GO:0016241	regulation of macroautophagy	1/50	171/18670	0.3691	0.4833	0.4331	RRAGD	1
BP	GO:0043901	negative regulation of multi-organism process	1/50	171/18670	0.3691	0.4833	0.4331	APCS	1
BP	GO:0060401	cytosolic calcium ion transport	1/50	171/18670	0.3691	0.4833	0.4331	CCR7	1
BP	GO:1901987	regulation of cell cycle phase transition	2/50	480/18670	0.3695	0.4833	0.4331	ERCC2/CCND2	2
BP	GO:0030324	lung development	1/50	172/18670	0.3708	0.4836	0.4334	RAB3A	1
BP	GO:0032874	positive regulation of stress-activated MAPK cascade	1/50	172/18670	0.3708	0.4836	0.4334	CCR7	1
BP	GO:0140013	meiotic nuclear division	1/50	172/18670	0.3708	0.4836	0.4334	PRDM7	1
BP	GO:0015711	organic anion transport	2/50	482/18670	0.3714	0.4838	0.4336	RAB3A/SLC25A20	2
BP	GO:0003018	vascular process in circulatory system	1/50	173/18670	0.3725	0.4839	0.4336	ADRA2B	1
BP	GO:0010469	regulation of signaling receptor activity	1/50	173/18670	0.3725	0.4839	0.4336	ADRA2B	1
BP	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	1/50	173/18670	0.3725	0.4839	0.4336	CCR7	1
BP	GO:0046488	phosphatidylinositol metabolic process	1/50	174/18670	0.3742	0.4851	0.4348	PIK3R5	1
BP	GO:0043312	neutrophil degranulation	2/50	485/18670	0.3743	0.4851	0.4348	RAB3A/C3	2
BP	GO:0002283	neutrophil activation involved in immune response	2/50	488/18670	0.3772	0.488	0.4373	RAB3A/C3	2
BP	GO:0006986	response to unfolded protein	1/50	176/18670	0.3776	0.488	0.4373	NFE2L2	1
BP	GO:0030323	respiratory tube development	1/50	176/18670	0.3776	0.488	0.4373	RAB3A	1
BP	GO:0022406	membrane docking	1/50	178/18670	0.381	0.4901	0.4392	RAB3A	1
BP	GO:0006479	protein methylation	1/50	179/18670	0.3827	0.4901	0.4392	PRDM7	1
BP	GO:0008064	regulation of actin polymerization or depolymerization	1/50	179/18670	0.3827	0.4901	0.4392	CCR7	1
BP	GO:0008213	protein alkylation	1/50	179/18670	0.3827	0.4901	0.4392	PRDM7	1
BP	GO:0008361	regulation of cell size	1/50	179/18670	0.3827	0.4901	0.4392	TRIM46	1
BP	GO:0048736	appendage development	1/50	179/18670	0.3827	0.4901	0.4392	FRAS1	1
BP	GO:0051099	positive regulation of binding	1/50	179/18670	0.3827	0.4901	0.4392	ERCC2	1
BP	GO:0060173	limb development	1/50	179/18670	0.3827	0.4901	0.4392	FRAS1	1
BP	GO:0030705	cytoskeleton-dependent intracellular transport	1/50	180/18670	0.3843	0.4901	0.4392	TRIM46	1
BP	GO:0030832	regulation of actin filament length	1/50	180/18670	0.3843	0.4901	0.4392	CCR7	1
BP	GO:0043534	blood vessel endothelial cell migration	1/50	180/18670	0.3843	0.4901	0.4392	NFE2L2	1
BP	GO:0071346	cellular response to interferon-gamma	1/50	180/18670	0.3843	0.4901	0.4392	OAS2	1
BP	GO:1901796	regulation of signal transduction by p53 class mediator	1/50	180/18670	0.3843	0.4901	0.4392	NOC2L	1
BP	GO:0002285	lymphocyte activation involved in immune response	1/50	181/18670	0.386	0.4901	0.4392	CD180	1
BP	GO:0010565	regulation of cellular ketone metabolic process	1/50	181/18670	0.386	0.4901	0.4392	LPGAT1	1
BP	GO:0042119	neutrophil activation	2/50	498/18670	0.3868	0.4901	0.4392	RAB3A/C3	2
BP	GO:0008217	regulation of blood pressure	1/50	182/18670	0.3877	0.4901	0.4392	ADRA2B	1
BP	GO:0009566	fertilization	1/50	182/18670	0.3877	0.4901	0.4392	RAB3A	1
BP	GO:0019884	antigen processing and presentation of exogenous antigen	1/50	182/18670	0.3877	0.4901	0.4392	CD1B	1
BP	GO:0030041	actin filament polymerization	1/50	182/18670	0.3877	0.4901	0.4392	CCR7	1
BP	GO:0002446	neutrophil mediated immunity	2/50	499/18670	0.3877	0.4901	0.4392	RAB3A/C3	2
BP	GO:0031667	response to nutrient levels	2/50	499/18670	0.3877	0.4901	0.4392	RRAGD/NFE2L2	2
BP	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	1/50	183/18670	0.3893	0.4907	0.4397	CCR7	1
BP	GO:0050770	regulation of axonogenesis	1/50	183/18670	0.3893	0.4907	0.4397	TRIM46	1
BP	GO:0061136	regulation of proteasomal protein catabolic process	1/50	183/18670	0.3893	0.4907	0.4397	NFE2L2	1
BP	GO:2000045	regulation of G1/S transition of mitotic cell cycle	1/50	184/18670	0.391	0.4923	0.4411	CCND2	1
BP	GO:0007369	gastrulation	1/50	185/18670	0.3926	0.4929	0.4417	ACVR2A	1
BP	GO:0046328	regulation of JNK cascade	1/50	185/18670	0.3926	0.4929	0.4417	CCR7	1
BP	GO:1902275	regulation of chromatin organization	1/50	185/18670	0.3926	0.4929	0.4417	NOC2L	1
BP	GO:0030308	negative regulation of cell growth	1/50	186/18670	0.3942	0.4945	0.4431	TRIM46	1
BP	GO:0019933	cAMP-mediated signaling	1/50	187/18670	0.3959	0.4952	0.4437	ADRA2B	1
BP	GO:0048167	regulation of synaptic plasticity	1/50	187/18670	0.3959	0.4952	0.4437	RAB3A	1
BP	GO:0006367	transcription initiation from RNA polymerase II promoter	1/50	188/18670	0.3975	0.4952	0.4437	ERCC2	1
BP	GO:0031345	negative regulation of cell projection organization	1/50	188/18670	0.3975	0.4952	0.4437	TRIM46	1
BP	GO:0043902	positive regulation of multi-organism process	1/50	188/18670	0.3975	0.4952	0.4437	CD180	1
BP	GO:0051783	regulation of nuclear division	1/50	188/18670	0.3975	0.4952	0.4437	PRDM7	1
BP	GO:1903046	meiotic cell cycle process	1/50	188/18670	0.3975	0.4952	0.4437	PRDM7	1
BP	GO:0071248	cellular response to metal ion	1/50	190/18670	0.4008	0.4987	0.4469	NFE2L2	1
BP	GO:0006333	chromatin assembly or disassembly	1/50	191/18670	0.4024	0.4998	0.4479	NOC2L	1
BP	GO:0071478	cellular response to radiation	1/50	191/18670	0.4024	0.4998	0.4479	NOC2L	1
BP	GO:0007565	female pregnancy	1/50	192/18670	0.404	0.5008	0.4488	ADRA2B	1
BP	GO:0044272	sulfur compound biosynthetic process	1/50	192/18670	0.404	0.5008	0.4488	NFE2L2	1
BP	GO:0006399	tRNA metabolic process	1/50	193/18670	0.4056	0.5018	0.4497	TSEN54	1
BP	GO:1901654	response to ketone	1/50	193/18670	0.4056	0.5018	0.4497	CCR7	1
BP	GO:0099504	synaptic vesicle cycle	1/50	194/18670	0.4072	0.5033	0.4511	RAB3A	1
BP	GO:2000377	regulation of reactive oxygen species metabolic process	1/50	195/18670	0.4088	0.5048	0.4524	NFE2L2	1
BP	GO:0002685	regulation of leukocyte migration	1/50	196/18670	0.4104	0.5058	0.4533	CCR7	1
BP	GO:0006694	steroid biosynthetic process	1/50	196/18670	0.4104	0.5058	0.4533	RDH8	1
BP	GO:0060541	respiratory system development	1/50	198/18670	0.4136	0.5093	0.4564	RAB3A	1
BP	GO:0007179	transforming growth factor beta receptor signaling pathway	1/50	199/18670	0.4152	0.5093	0.4564	ACVR2A	1
BP	GO:0017038	protein import	1/50	199/18670	0.4152	0.5093	0.4564	PEX10	1
BP	GO:0034341	response to interferon-gamma	1/50	199/18670	0.4152	0.5093	0.4564	OAS2	1
BP	GO:0035966	response to topologically incorrect protein	1/50	199/18670	0.4152	0.5093	0.4564	NFE2L2	1
BP	GO:0006575	cellular modified amino acid metabolic process	1/50	202/18670	0.42	0.5131	0.4598	NFE2L2	1
BP	GO:0050852	T cell receptor signaling pathway	1/50	202/18670	0.42	0.5131	0.4598	CCR7	1
BP	GO:0050870	positive regulation of T cell activation	1/50	202/18670	0.42	0.5131	0.4598	CCR7	1
BP	GO:1902806	regulation of cell cycle G1/S phase transition	1/50	202/18670	0.42	0.5131	0.4598	CCND2	1
BP	GO:0007266	Rho protein signal transduction	1/50	203/18670	0.4215	0.514	0.4606	PHACTR4	1
BP	GO:0030278	regulation of ossification	1/50	203/18670	0.4215	0.514	0.4606	ACVR2A	1
BP	GO:0006473	protein acetylation	1/50	204/18670	0.4231	0.515	0.4615	NOC2L	1
BP	GO:1902905	positive regulation of supramolecular fiber organization	1/50	204/18670	0.4231	0.515	0.4615	CCR7	1
BP	GO:0071222	cellular response to lipopolysaccharide	1/50	205/18670	0.4246	0.5164	0.4627	CD180	1
BP	GO:0006643	membrane lipid metabolic process	1/50	207/18670	0.4278	0.5192	0.4652	GAL3ST4	1
BP	GO:0071456	cellular response to hypoxia	1/50	207/18670	0.4278	0.5192	0.4652	NFE2L2	1
BP	GO:0050792	regulation of viral process	1/50	208/18670	0.4293	0.5205	0.4665	APCS	1
BP	GO:0008154	actin polymerization or depolymerization	1/50	209/18670	0.4309	0.5213	0.4672	CCR7	1
BP	GO:0051701	interaction with host	1/50	209/18670	0.4309	0.5213	0.4672	APCS	1
BP	GO:0006323	DNA packaging	1/50	210/18670	0.4324	0.5213	0.4672	NOC2L	1
BP	GO:0007163	establishment or maintenance of cell polarity	1/50	210/18670	0.4324	0.5213	0.4672	CCR7	1
BP	GO:0050707	regulation of cytokine secretion	1/50	210/18670	0.4324	0.5213	0.4672	CCR7	1
BP	GO:0097529	myeloid leukocyte migration	1/50	210/18670	0.4324	0.5213	0.4672	CCR7	1
BP	GO:1903531	negative regulation of secretion by cell	1/50	211/18670	0.4339	0.5227	0.4684	ADRA2B	1
BP	GO:0006888	ER to Golgi vesicle-mediated transport	1/50	212/18670	0.4355	0.5235	0.4692	COPB2	1
BP	GO:0071219	cellular response to molecule of bacterial origin	1/50	212/18670	0.4355	0.5235	0.4692	CD180	1
BP	GO:0007254	JNK cascade	1/50	214/18670	0.4385	0.5251	0.4706	CCR7	1
BP	GO:0045732	positive regulation of protein catabolic process	1/50	214/18670	0.4385	0.5251	0.4706	NFE2L2	1
BP	GO:1903050	regulation of proteolysis involved in cellular protein catabolic process	1/50	214/18670	0.4385	0.5251	0.4706	NFE2L2	1
BP	GO:0008037	cell recognition	1/50	215/18670	0.44	0.5251	0.4706	CCR7	1
BP	GO:0010810	regulation of cell-substrate adhesion	1/50	215/18670	0.44	0.5251	0.4706	CCR7	1
BP	GO:0019935	cyclic-nucleotide-mediated signaling	1/50	215/18670	0.44	0.5251	0.4706	ADRA2B	1
BP	GO:0032388	positive regulation of intracellular transport	1/50	215/18670	0.44	0.5251	0.4706	TRIM46	1
BP	GO:0008406	gonad development	1/50	217/18670	0.4431	0.5251	0.4706	ACVR2A	1
BP	GO:0017157	regulation of exocytosis	1/50	217/18670	0.4431	0.5251	0.4706	RAB3A	1
BP	GO:0036294	cellular response to decreased oxygen levels	1/50	217/18670	0.4431	0.5251	0.4706	NFE2L2	1
BP	GO:0046474	glycerophospholipid biosynthetic process	1/50	217/18670	0.4431	0.5251	0.4706	PIK3R5	1
BP	GO:0050920	regulation of chemotaxis	1/50	217/18670	0.4431	0.5251	0.4706	CCR7	1
BP	GO:0060348	bone development	1/50	217/18670	0.4431	0.5251	0.4706	THPO	1
BP	GO:0071241	cellular response to inorganic substance	1/50	217/18670	0.4431	0.5251	0.4706	NFE2L2	1
BP	GO:0007601	visual perception	1/50	218/18670	0.4446	0.5251	0.4706	RDH8	1
BP	GO:0019722	calcium-mediated signaling	1/50	218/18670	0.4446	0.5251	0.4706	CCR7	1
BP	GO:0032271	regulation of protein polymerization	1/50	218/18670	0.4446	0.5251	0.4706	CCR7	1
BP	GO:0032886	regulation of microtubule-based process	1/50	218/18670	0.4446	0.5251	0.4706	TRIM46	1
BP	GO:1903039	positive regulation of leukocyte cell-cell adhesion	1/50	218/18670	0.4446	0.5251	0.4706	CCR7	1
BP	GO:0009952	anterior/posterior pattern specification	1/50	219/18670	0.4461	0.5259	0.4713	ACVR2A	1
BP	GO:0048762	mesenchymal cell differentiation	1/50	219/18670	0.4461	0.5259	0.4713	PHACTR4	1
BP	GO:0007188	adenylate cyclase-modulating G protein-coupled receptor signaling pathway	1/50	221/18670	0.4491	0.529	0.474	ADRA2B	1
BP	GO:0043903	regulation of symbiosis, encompassing mutualism through parasitism	1/50	222/18670	0.4506	0.5298	0.4747	APCS	1
BP	GO:0050953	sensory perception of light stimulus	1/50	222/18670	0.4506	0.5298	0.4747	RDH8	1
BP	GO:0045137	development of primary sexual characteristics	1/50	223/18670	0.4521	0.531	0.4759	ACVR2A	1
BP	GO:0030595	leukocyte chemotaxis	1/50	224/18670	0.4536	0.5323	0.477	CCR7	1
BP	GO:0001649	osteoblast differentiation	1/50	225/18670	0.455	0.533	0.4777	ACVR2A	1
BP	GO:0007160	cell-matrix adhesion	1/50	225/18670	0.455	0.533	0.4777	CCR7	1
BP	GO:0051495	positive regulation of cytoskeleton organization	1/50	226/18670	0.4565	0.5343	0.4788	CCR7	1
BP	GO:0006457	protein folding	1/50	227/18670	0.458	0.5355	0.4799	APCS	1
BP	GO:0010594	regulation of endothelial cell migration	1/50	229/18670	0.4609	0.5384	0.4825	NFE2L2	1
BP	GO:0042445	hormone metabolic process	1/50	232/18670	0.4653	0.5431	0.4867	RDH8	1
BP	GO:0097305	response to alcohol	1/50	233/18670	0.4667	0.5443	0.4877	CCR7	1
BP	GO:0048588	developmental cell growth	1/50	234/18670	0.4682	0.5449	0.4883	TRIM46	1
BP	GO:0071453	cellular response to oxygen levels	1/50	234/18670	0.4682	0.5449	0.4883	NFE2L2	1
BP	GO:0060560	developmental growth involved in morphogenesis	1/50	235/18670	0.4696	0.5461	0.4894	TRIM46	1
BP	GO:0071216	cellular response to biotic stimulus	1/50	236/18670	0.4711	0.5473	0.4905	CD180	1
BP	GO:0007050	cell cycle arrest	1/50	237/18670	0.4725	0.5475	0.4906	RRAGD	1
BP	GO:0032872	regulation of stress-activated MAPK cascade	1/50	237/18670	0.4725	0.5475	0.4906	CCR7	1
BP	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	1/50	237/18670	0.4725	0.5475	0.4906	CCR7	1
BP	GO:0051048	negative regulation of secretion	1/50	238/18670	0.4739	0.5481	0.4912	ADRA2B	1
BP	GO:0051607	defense response to virus	1/50	238/18670	0.4739	0.5481	0.4912	OAS2	1
BP	GO:0031348	negative regulation of defense response	1/50	239/18670	0.4754	0.5488	0.4918	APCS	1
BP	GO:0070302	regulation of stress-activated protein kinase signaling cascade	1/50	239/18670	0.4754	0.5488	0.4918	CCR7	1
BP	GO:0030217	T cell differentiation	1/50	240/18670	0.4768	0.5494	0.4924	CCR7	1
BP	GO:0050663	cytokine secretion	1/50	240/18670	0.4768	0.5494	0.4924	CCR7	1
BP	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	1/50	241/18670	0.4782	0.5506	0.4934	ACVR2A	1
CC	GO:1902554	serine/threonine protein kinase complex	3/51	88/19717	0.001532	0.1127	0.1034	ACVR2A/ERCC2/CCND2	3
CC	GO:0005604	basement membrane	3/51	95/19717	0.001909	0.1127	0.1034	LOXL1/FRAS1/COL9A2	3
CC	GO:1902911	protein kinase complex	3/51	109/19717	0.002822	0.1127	0.1034	ACVR2A/ERCC2/CCND2	3
CC	GO:0062023	collagen-containing extracellular matrix	5/51	406/19717	0.003899	0.1127	0.1034	LOXL1/FRAS1/C1QA/APCS/COL9A2	5
CC	GO:0061695	transferase complex, transferring phosphorus-containing groups	4/51	259/19717	0.00448	0.1127	0.1034	ACVR2A/ERCC2/PIK3R5/CCND2	4
CC	GO:0030018	Z disc	3/51	132/19717	0.004831	0.1127	0.1034	IGFN1/PPP1R12A/DES	3
CC	GO:0031674	I band	3/51	143/19717	0.006032	0.1206	0.1107	IGFN1/PPP1R12A/DES	3
CC	GO:0030017	sarcomere	3/51	204/19717	0.01579	0.264	0.2422	IGFN1/PPP1R12A/DES	3
CC	GO:0044449	contractile fiber part	3/51	221/19717	0.0195	0.264	0.2422	IGFN1/PPP1R12A/DES	3
CC	GO:0030016	myofibril	3/51	224/19717	0.0202	0.264	0.2422	IGFN1/PPP1R12A/DES	3
CC	GO:0005581	collagen trimer	2/51	87/19717	0.02134	0.264	0.2422	C1QA/COL9A2	2
CC	GO:0043292	contractile fiber	3/51	234/19717	0.02263	0.264	0.2422	IGFN1/PPP1R12A/DES	3
CC	GO:0005916	fascia adherens	1/51	10/19717	0.02557	0.2727	0.2502	DES	1
CC	GO:0060198	clathrin-sculpted vesicle	1/51	12/19717	0.03061	0.2727	0.2502	RAB3A	1
CC	GO:0001669	acrosomal vesicle	2/51	108/19717	0.03184	0.2727	0.2502	RAB3A/LOXL1	2
CC	GO:0005675	transcription factor TFIIH holo complex	1/51	13/19717	0.03312	0.2727	0.2502	ERCC2	1
CC	GO:0098993	anchored component of synaptic vesicle membrane	1/51	13/19717	0.03312	0.2727	0.2502	RAB3A	1
CC	GO:0030126	COPI vesicle coat	1/51	15/19717	0.03812	0.2965	0.272	COPB2	1
CC	GO:0030663	COPI-coated vesicle membrane	1/51	20/19717	0.0505	0.2989	0.2742	COPB2	1
CC	GO:0043186	P granule	1/51	20/19717	0.0505	0.2989	0.2742	DDX3Y	1
CC	GO:0043194	axon initial segment	1/51	20/19717	0.0505	0.2989	0.2742	TRIM46	1
CC	GO:0045495	pole plasm	1/51	20/19717	0.0505	0.2989	0.2742	DDX3Y	1
CC	GO:0060293	germ plasm	1/51	20/19717	0.0505	0.2989	0.2742	DDX3Y	1
CC	GO:0032806	carboxy-terminal domain protein kinase complex	1/51	21/19717	0.05296	0.2989	0.2742	ERCC2	1
CC	GO:0031258	lamellipodium membrane	1/51	22/19717	0.05541	0.2989	0.2742	PLEK2	1
CC	GO:0072562	blood microparticle	2/51	147/19717	0.05551	0.2989	0.2742	APCS/C3	2
CC	GO:0030687	preribosome, large subunit precursor	1/51	23/19717	0.05786	0.3	0.2752	NOC2L	1
CC	GO:0005942	phosphatidylinositol 3-kinase complex	1/51	27/19717	0.06758	0.3263	0.2993	PIK3R5	1
CC	GO:0030137	COPI-coated vesicle	1/51	27/19717	0.06758	0.3263	0.2993	COPB2	1
CC	GO:0030686	90S preribosome	1/51	31/19717	0.07721	0.3346	0.3069	NOC2L	1
CC	GO:1902555	endoribonuclease complex	1/51	31/19717	0.07721	0.3346	0.3069	TSEN54	1
CC	GO:1905348	endonuclease complex	1/51	32/19717	0.0796	0.3346	0.3069	TSEN54	1
CC	GO:0030662	coated vesicle membrane	2/51	182/19717	0.08054	0.3346	0.3069	RAB3A/COPB2	2
CC	GO:0009897	external side of plasma membrane	3/51	393/19717	0.08126	0.3346	0.3069	CD1B/TNFRSF9/CCR7	3
CC	GO:0097223	sperm part	2/51	191/19717	0.08745	0.3452	0.3166	RAB3A/LOXL1	2
CC	GO:0030027	lamellipodium	2/51	193/19717	0.08901	0.3452	0.3166	PHACTR4/PLEK2	2
CC	GO:0044798	nuclear transcription factor complex	2/51	201/19717	0.09534	0.3452	0.3166	TAF1B/ERCC2	2
CC	GO:0005669	transcription factor TFIID complex	1/51	39/19717	0.09616	0.3452	0.3166	ERCC2	1
CC	GO:0031672	A band	1/51	39/19717	0.09616	0.3452	0.3166	PPP1R12A	1
CC	GO:0000307	cyclin-dependent protein kinase holoenzyme complex	1/51	42/19717	0.1032	0.3611	0.3312	CCND2	1
CC	GO:0008287	protein serine/threonine phosphatase complex	1/51	45/19717	0.1101	0.3671	0.3367	PPP1R12A	1
CC	GO:1903293	phosphatase complex	1/51	45/19717	0.1101	0.3671	0.3367	PPP1R12A	1
CC	GO:0098563	intrinsic component of synaptic vesicle membrane	1/51	47/19717	0.1147	0.3736	0.3427	RAB3A	1
CC	GO:0014704	intercalated disc	1/51	50/19717	0.1216	0.377	0.3459	DES	1
CC	GO:0034707	chloride channel complex	1/51	50/19717	0.1216	0.377	0.3459	CLCNKA	1
CC	GO:0043195	terminal bouton	1/51	51/19717	0.1239	0.377	0.3459	RAB3A	1
CC	GO:1904115	axon cytoplasm	1/51	57/19717	0.1374	0.4035	0.3702	TRIM46	1
CC	GO:0030120	vesicle coat	1/51	58/19717	0.1397	0.4035	0.3702	COPB2	1
CC	GO:0005778	peroxisomal membrane	1/51	60/19717	0.1441	0.4035	0.3702	PEX10	1
CC	GO:0031903	microbody membrane	1/51	60/19717	0.1441	0.4035	0.3702	PEX10	1
CC	GO:0019005	SCF ubiquitin ligase complex	1/51	64/19717	0.153	0.4199	0.3852	SPSB2	1
CC	GO:0044304	main axon	1/51	68/19717	0.1617	0.4283	0.3928	TRIM46	1
CC	GO:0005905	clathrin-coated pit	1/51	69/19717	0.1639	0.4283	0.3928	LRP12	1
CC	GO:0044291	cell-cell contact zone	1/51	71/19717	0.1682	0.4283	0.3928	DES	1
CC	GO:0048786	presynaptic active zone	1/51	71/19717	0.1682	0.4283	0.3928	RAB3A	1
CC	GO:0030135	coated vesicle	2/51	289/19717	0.1717	0.4292	0.3937	RAB3A/COPB2	2
CC	GO:0030684	preribosome	1/51	76/19717	0.179	0.432	0.3963	NOC2L	1
CC	GO:0031594	neuromuscular junction	1/51	76/19717	0.179	0.432	0.3963	DES	1
CC	GO:0005788	endoplasmic reticulum lumen	2/51	309/19717	0.1903	0.4423	0.4057	C3/COL9A2	2
CC	GO:0005902	microvillus	1/51	83/19717	0.1938	0.4423	0.4057	CD302	1
CC	GO:0016591	RNA polymerase II, holoenzyme	1/51	83/19717	0.1938	0.4423	0.4057	ERCC2	1
CC	GO:0120111	neuron projection cytoplasm	1/51	84/19717	0.1959	0.4423	0.4057	TRIM46	1
CC	GO:0035578	azurophil granule lumen	1/51	91/19717	0.2104	0.4586	0.4207	C3	1
CC	GO:0032580	Golgi cisterna membrane	1/51	92/19717	0.2124	0.4586	0.4207	GAL3ST4	1
CC	GO:0030117	membrane coat	1/51	96/19717	0.2206	0.4586	0.4207	COPB2	1
CC	GO:0048475	coated membrane	1/51	96/19717	0.2206	0.4586	0.4207	COPB2	1
CC	GO:0044438	microbody part	1/51	100/19717	0.2287	0.4586	0.4207	PEX10	1
CC	GO:0044439	peroxisomal part	1/51	100/19717	0.2287	0.4586	0.4207	PEX10	1
CC	GO:0030175	filopodium	1/51	104/19717	0.2367	0.4586	0.4207	CD302	1
CC	GO:0030672	synaptic vesicle membrane	1/51	104/19717	0.2367	0.4586	0.4207	RAB3A	1
CC	GO:0099501	exocytic vesicle membrane	1/51	104/19717	0.2367	0.4586	0.4207	RAB3A	1
CC	GO:0055029	nuclear DNA-directed RNA polymerase complex	1/51	107/19717	0.2426	0.4586	0.4207	ERCC2	1
CC	GO:0005667	transcription factor complex	2/51	365/19717	0.2435	0.4586	0.4207	TAF1B/ERCC2	2
CC	GO:0000428	DNA-directed RNA polymerase complex	1/51	108/19717	0.2446	0.4586	0.4207	ERCC2	1
CC	GO:0030880	RNA polymerase complex	1/51	112/19717	0.2524	0.4586	0.4207	ERCC2	1
CC	GO:0030660	Golgi-associated vesicle membrane	1/51	114/19717	0.2563	0.4586	0.4207	COPB2	1
CC	GO:0030665	clathrin-coated vesicle membrane	1/51	115/19717	0.2582	0.4586	0.4207	RAB3A	1
CC	GO:0033267	axon part	2/51	382/19717	0.2598	0.4586	0.4207	RAB3A/TRIM46	2
CC	GO:0031985	Golgi cisterna	1/51	116/19717	0.2602	0.4586	0.4207	GAL3ST4	1
CC	GO:0005913	cell-cell adherens junction	1/51	117/19717	0.2621	0.4586	0.4207	DES	1
CC	GO:0043679	axon terminus	1/51	119/19717	0.2659	0.4596	0.4216	RAB3A	1
CC	GO:0030133	transport vesicle	2/51	392/19717	0.2694	0.46	0.4219	RAB3A/COPB2	2
CC	GO:0031252	cell leading edge	2/51	403/19717	0.28	0.4723	0.4332	PHACTR4/PLEK2	2
CC	GO:0005774	vacuolar membrane	2/51	412/19717	0.2887	0.4737	0.4345	CD1B/RRAGD	2
CC	GO:0005777	peroxisome	1/51	134/19717	0.2941	0.4737	0.4345	PEX10	1
CC	GO:0042579	microbody	1/51	134/19717	0.2941	0.4737	0.4345	PEX10	1
CC	GO:0000776	kinetochore	1/51	135/19717	0.2959	0.4737	0.4345	PPP1R12A	1
CC	GO:0042383	sarcolemma	1/51	136/19717	0.2977	0.4737	0.4345	DES	1
CC	GO:0044306	neuron projection terminus	1/51	138/19717	0.3014	0.4741	0.4349	RAB3A	1
CC	GO:0005795	Golgi stack	1/51	149/19717	0.3212	0.4996	0.4583	GAL3ST4	1
CC	GO:0005766	primary lysosome	1/51	155/19717	0.3317	0.5048	0.463	C3	1
CC	GO:0042582	azurophil granule	1/51	155/19717	0.3317	0.5048	0.463	C3	1
CC	GO:0031461	cullin-RING ubiquitin ligase complex	1/51	158/19717	0.3369	0.5072	0.4652	SPSB2	1
CC	GO:0090575	RNA polymerase II transcription factor complex	1/51	163/19717	0.3455	0.5146	0.472	ERCC2	1
CC	GO:0031225	anchored component of membrane	1/51	170/19717	0.3574	0.5206	0.4776	RAB3A	1
CC	GO:0031256	leading edge membrane	1/51	170/19717	0.3574	0.5206	0.4776	PLEK2	1
CC	GO:0005775	vacuolar lumen	1/51	172/19717	0.3607	0.5206	0.4776	C3	1
CC	GO:0005798	Golgi-associated vesicle	1/51	178/19717	0.3707	0.5242	0.4808	COPB2	1
CC	GO:0044452	nucleolar part	1/51	178/19717	0.3707	0.5242	0.4808	TAF1B	1
CC	GO:0030136	clathrin-coated vesicle	1/51	188/19717	0.3869	0.5417	0.4969	RAB3A	1
CC	GO:0008021	synaptic vesicle	1/51	191/19717	0.3917	0.542	0.4972	RAB3A	1
CC	GO:0000775	chromosome, centromeric region	1/51	193/19717	0.3949	0.542	0.4972	PPP1R12A	1
MF	GO:0019199	transmembrane receptor protein kinase activity	2/52	79/17697	0.02259	0.2689	0.2379	ACVR2A/LTK	2
MF	GO:0015651	quaternary ammonium group transmembrane transporter activity	1/52	10/17697	0.02901	0.2689	0.2379	SLC25A20	1
MF	GO:0046790	virion binding	1/52	10/17697	0.02901	0.2689	0.2379	APCS	1
MF	GO:0071723	lipopeptide binding	1/52	10/17697	0.02901	0.2689	0.2379	CD1B	1
MF	GO:0004303	estradiol 17-beta-dehydrogenase activity	1/52	11/17697	0.03186	0.2689	0.2379	RDH8	1
MF	GO:0005247	voltage-gated chloride channel activity	1/52	11/17697	0.03186	0.2689	0.2379	CLCNKA	1
MF	GO:0034713	type I transforming growth factor beta receptor binding	1/52	11/17697	0.03186	0.2689	0.2379	ACVR2A	1
MF	GO:0052650	NADP-retinol dehydrogenase activity	1/52	11/17697	0.03186	0.2689	0.2379	RDH8	1
MF	GO:0019208	phosphatase regulator activity	2/52	96/17697	0.0324	0.2689	0.2379	PHACTR4/PPP1R12A	2
MF	GO:0005041	low-density lipoprotein particle receptor activity	1/52	12/17697	0.03471	0.2689	0.2379	LRP12	1
MF	GO:0072542	protein phosphatase activator activity	1/52	13/17697	0.03754	0.2689	0.2379	PHACTR4	1
MF	GO:0046935	1-phosphatidylinositol-3-kinase regulator activity	1/52	14/17697	0.04037	0.2689	0.2379	PIK3R5	1
MF	GO:0048185	activin binding	1/52	14/17697	0.04037	0.2689	0.2379	ACVR2A	1
MF	GO:0001846	opsonin binding	1/52	15/17697	0.0432	0.2689	0.2379	APCS	1
MF	GO:0003841	1-acylglycerol-3-phosphate O-acyltransferase activity	1/52	15/17697	0.0432	0.2689	0.2379	LPGAT1	1
MF	GO:0005024	transforming growth factor beta-activated receptor activity	1/52	15/17697	0.0432	0.2689	0.2379	ACVR2A	1
MF	GO:0030228	lipoprotein particle receptor activity	1/52	15/17697	0.0432	0.2689	0.2379	LRP12	1
MF	GO:0042171	lysophosphatidic acid acyltransferase activity	1/52	15/17697	0.0432	0.2689	0.2379	LPGAT1	1
MF	GO:0003996	acyl-CoA ligase activity	1/52	16/17697	0.04601	0.2689	0.2379	ACSF2	1
MF	GO:0016641	oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor	1/52	16/17697	0.04601	0.2689	0.2379	LOXL1	1
MF	GO:0016881	acid-amino acid ligase activity	1/52	16/17697	0.04601	0.2689	0.2379	TTLL1	1
MF	GO:0019211	phosphatase activator activity	1/52	16/17697	0.04601	0.2689	0.2379	PHACTR4	1
MF	GO:0030169	low-density lipoprotein particle binding	1/52	16/17697	0.04601	0.2689	0.2379	APCS	1
MF	GO:0042800	histone methyltransferase activity (H3-K4 specific)	1/52	16/17697	0.04601	0.2689	0.2379	PRDM7	1
MF	GO:0071617	lysophospholipid acyltransferase activity	1/52	16/17697	0.04601	0.2689	0.2379	LPGAT1	1
MF	GO:0004549	tRNA-specific ribonuclease activity	1/52	17/17697	0.04882	0.2689	0.2379	TSEN54	1
MF	GO:0004675	transmembrane receptor protein serine/threonine kinase activity	1/52	17/17697	0.04882	0.2689	0.2379	ACVR2A	1
MF	GO:0004935	adrenergic receptor activity	1/52	17/17697	0.04882	0.2689	0.2379	ADRA2B	1
MF	GO:0008308	voltage-gated anion channel activity	1/52	17/17697	0.04882	0.2689	0.2379	CLCNKA	1
MF	GO:0031489	myosin V binding	1/52	17/17697	0.04882	0.2689	0.2379	RAB3A	1
MF	GO:0035014	phosphatidylinositol 3-kinase regulator activity	1/52	17/17697	0.04882	0.2689	0.2379	PIK3R5	1
MF	GO:0008353	RNA polymerase II CTD heptapeptide repeat kinase activity	1/52	18/17697	0.05161	0.2689	0.2379	ERCC2	1
MF	GO:0004745	retinol dehydrogenase activity	1/52	20/17697	0.05718	0.2689	0.2379	RDH8	1
MF	GO:0008157	protein phosphatase 1 binding	1/52	20/17697	0.05718	0.2689	0.2379	PHACTR4	1
MF	GO:0016638	oxidoreductase activity, acting on the CH-NH2 group of donors	1/52	20/17697	0.05718	0.2689	0.2379	LOXL1	1
MF	GO:0031683	G-protein beta/gamma-subunit complex binding	1/52	20/17697	0.05718	0.2689	0.2379	PIK3R5	1
MF	GO:1901338	catecholamine binding	1/52	20/17697	0.05718	0.2689	0.2379	ADRA2B	1
MF	GO:0001848	complement binding	1/52	21/17697	0.05996	0.2689	0.2379	APCS	1
MF	GO:0008106	alcohol dehydrogenase (NADP+) activity	1/52	21/17697	0.05996	0.2689	0.2379	RDH8	1
MF	GO:0016411	acylglycerol O-acyltransferase activity	1/52	21/17697	0.05996	0.2689	0.2379	LPGAT1	1
MF	GO:0016894	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters	1/52	21/17697	0.05996	0.2689	0.2379	TSEN54	1
MF	GO:0017025	TBP-class protein binding	1/52	22/17697	0.06272	0.2689	0.2379	TAF1B	1
MF	GO:0030742	GTP-dependent protein binding	1/52	22/17697	0.06272	0.2689	0.2379	RAB3A	1
MF	GO:0016493	C-C chemokine receptor activity	1/52	23/17697	0.06548	0.2689	0.2379	CCR7	1
MF	GO:0016874	ligase activity	2/52	145/17697	0.06777	0.2689	0.2379	ACSF2/TTLL1	2
MF	GO:0019957	C-C chemokine binding	1/52	24/17697	0.06823	0.2689	0.2379	CCR7	1
MF	GO:0001671	ATPase activator activity	1/52	25/17697	0.07097	0.2689	0.2379	RAB3A	1
MF	GO:0015101	organic cation transmembrane transporter activity	1/52	25/17697	0.07097	0.2689	0.2379	SLC25A20	1
MF	GO:0001637	G protein-coupled chemoattractant receptor activity	1/52	26/17697	0.07371	0.2689	0.2379	CCR7	1
MF	GO:0004033	aldo-keto reductase (NADP) activity	1/52	26/17697	0.07371	0.2689	0.2379	RDH8	1
MF	GO:0004950	chemokine receptor activity	1/52	26/17697	0.07371	0.2689	0.2379	CCR7	1
MF	GO:0016405	CoA-ligase activity	1/52	26/17697	0.07371	0.2689	0.2379	ACSF2	1
MF	GO:0080025	phosphatidylinositol-3,5-bisphosphate binding	1/52	28/17697	0.07915	0.2689	0.2379	PLEK2	1
MF	GO:0033764	steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	1/52	29/17697	0.08186	0.2689	0.2379	RDH8	1
MF	GO:0070566	adenylyltransferase activity	1/52	29/17697	0.08186	0.2689	0.2379	OAS2	1
MF	GO:0071889	14-3-3 protein binding	1/52	29/17697	0.08186	0.2689	0.2379	PPP1R12A	1
MF	GO:0004386	helicase activity	2/52	163/17697	0.08294	0.2689	0.2379	ERCC2/DDX3Y	2
MF	GO:0005201	extracellular matrix structural constituent	2/52	163/17697	0.08294	0.2689	0.2379	FRAS1/COL9A2	2
MF	GO:0008519	ammonium transmembrane transporter activity	1/52	30/17697	0.08456	0.2689	0.2379	SLC25A20	1
MF	GO:0016878	acid-thiol ligase activity	1/52	30/17697	0.08456	0.2689	0.2379	ACSF2	1
MF	GO:0043325	phosphatidylinositol-3,4-bisphosphate binding	1/52	30/17697	0.08456	0.2689	0.2379	PLEK2	1
MF	GO:0030674	protein binding, bridging	2/52	170/17697	0.08909	0.2764	0.2445	ERCC2/SPSB2	2
MF	GO:0019956	chemokine binding	1/52	32/17697	0.08994	0.2764	0.2445	CCR7	1
MF	GO:0071813	lipoprotein particle binding	1/52	33/17697	0.09262	0.2764	0.2445	APCS	1
MF	GO:0071814	protein-lipid complex binding	1/52	33/17697	0.09262	0.2764	0.2445	APCS	1
MF	GO:0016229	steroid dehydrogenase activity	1/52	35/17697	0.09796	0.2879	0.2547	RDH8	1
MF	GO:0008022	protein C-terminus binding	2/52	187/17697	0.1046	0.3028	0.2678	RAB3A/ERCC2	2
MF	GO:0032266	phosphatidylinositol-3-phosphate binding	1/52	39/17697	0.1085	0.3066	0.2711	PLEK2	1
MF	GO:0016877	ligase activity, forming carbon-sulfur bonds	1/52	40/17697	0.1112	0.3066	0.2711	ACSF2	1
MF	GO:0060590	ATPase regulator activity	1/52	40/17697	0.1112	0.3066	0.2711	RAB3A	1
MF	GO:0030020	extracellular matrix structural constituent conferring tensile strength	1/52	41/17697	0.1138	0.3066	0.2711	COL9A2	1
MF	GO:0051539	4 iron, 4 sulfur cluster binding	1/52	41/17697	0.1138	0.3066	0.2711	ERCC2	1
MF	GO:0001221	transcription cofactor binding	1/52	43/17697	0.119	0.3088	0.2731	NFE2L2	1
MF	GO:0015026	coreceptor activity	1/52	44/17697	0.1216	0.3088	0.2731	ACVR2A	1
MF	GO:0016879	ligase activity, forming carbon-nitrogen bonds	1/52	44/17697	0.1216	0.3088	0.2731	TTLL1	1
MF	GO:0018024	histone-lysine N-methyltransferase activity	1/52	44/17697	0.1216	0.3088	0.2731	PRDM7	1
MF	GO:0019207	kinase regulator activity	2/52	207/17697	0.1237	0.3088	0.2731	PIK3R5/CCND2	2
MF	GO:0001046	core promoter sequence-specific DNA binding	1/52	45/17697	0.1242	0.3088	0.2731	TAF1B	1
MF	GO:0008374	O-acyltransferase activity	1/52	47/17697	0.1293	0.3176	0.2809	LPGAT1	1
MF	GO:0016538	cyclin-dependent protein serine/threonine kinase regulator activity	1/52	49/17697	0.1344	0.326	0.2884	CCND2	1
MF	GO:0005160	transforming growth factor beta receptor binding	1/52	51/17697	0.1395	0.3342	0.2956	ACVR2A	1
MF	GO:0008146	sulfotransferase activity	1/52	52/17697	0.1421	0.3361	0.2973	GAL3ST4	1
MF	GO:0001102	RNA polymerase II activating transcription factor binding	1/52	53/17697	0.1446	0.338	0.2989	NFE2L2	1
MF	GO:0001047	core promoter binding	1/52	55/17697	0.1496	0.341	0.3016	TAF1B	1
MF	GO:0043621	protein self-association	1/52	56/17697	0.1521	0.341	0.3016	ACVR2A	1
MF	GO:0060090	molecular adaptor activity	2/52	237/17697	0.1537	0.341	0.3016	ERCC2/SPSB2	2
MF	GO:0042054	histone methyltransferase activity	1/52	57/17697	0.1546	0.341	0.3016	PRDM7	1
MF	GO:0003714	transcription corepressor activity	2/52	238/17697	0.1547	0.341	0.3016	ZBTB32/NOC2L	2
MF	GO:0005507	copper ion binding	1/52	59/17697	0.1596	0.3441	0.3043	LOXL1	1
MF	GO:0008227	G protein-coupled amine receptor activity	1/52	59/17697	0.1596	0.3441	0.3043	ADRA2B	1
MF	GO:0016279	protein-lysine N-methyltransferase activity	1/52	60/17697	0.1621	0.3456	0.3056	PRDM7	1
MF	GO:0016278	lysine N-methyltransferase activity	1/52	61/17697	0.1646	0.3461	0.3061	PRDM7	1
MF	GO:0004714	transmembrane receptor protein tyrosine kinase activity	1/52	62/17697	0.167	0.3461	0.3061	LTK	1
MF	GO:0051536	iron-sulfur cluster binding	1/52	63/17697	0.1695	0.3461	0.3061	ERCC2	1
MF	GO:0051540	metal cluster binding	1/52	63/17697	0.1695	0.3461	0.3061	ERCC2	1
MF	GO:0004521	endoribonuclease activity	1/52	64/17697	0.1719	0.3475	0.3073	TSEN54	1
MF	GO:0003684	damaged DNA binding	1/52	65/17697	0.1744	0.3488	0.3085	ERCC2	1
MF	GO:0008094	DNA-dependent ATPase activity	1/52	69/17697	0.1841	0.3598	0.3182	ERCC2	1
MF	GO:0016782	transferase activity, transferring sulfur-containing groups	1/52	69/17697	0.1841	0.3598	0.3182	GAL3ST4	1
MF	GO:0017022	myosin binding	1/52	71/17697	0.1889	0.3598	0.3182	RAB3A	1
MF	GO:0070491	repressing transcription factor binding	1/52	71/17697	0.1889	0.3598	0.3182	NOC2L	1
MF	GO:0030246	carbohydrate binding	2/52	271/17697	0.1892	0.3598	0.3182	CD302/APCS	2
MF	GO:0019003	GDP binding	1/52	74/17697	0.196	0.3666	0.3242	RRAGD	1
MF	GO:0003725	double-stranded RNA binding	1/52	75/17697	0.1984	0.3666	0.3242	OAS2	1
MF	GO:0005254	chloride channel activity	1/52	75/17697	0.1984	0.3666	0.3242	CLCNKA	1
MF	GO:0001540	amyloid-beta binding	1/52	78/17697	0.2055	0.3722	0.3292	C1QA	1
MF	GO:0003724	RNA helicase activity	1/52	78/17697	0.2055	0.3722	0.3292	DDX3Y	1
MF	GO:0046332	SMAD binding	1/52	80/17697	0.2102	0.3722	0.3292	ACVR2A	1
MF	GO:0051117	ATPase binding	1/52	80/17697	0.2102	0.3722	0.3292	RAB3A	1
MF	GO:0003678	DNA helicase activity	1/52	81/17697	0.2125	0.3722	0.3292	ERCC2	1
MF	GO:0019888	protein phosphatase regulator activity	1/52	82/17697	0.2148	0.3722	0.3292	PHACTR4	1
MF	GO:0042277	peptide binding	2/52	295/17697	0.2149	0.3722	0.3292	CD1B/C1QA	2
MF	GO:0031491	nucleosome binding	1/52	85/17697	0.2218	0.3741	0.3309	NOC2L	1
MF	GO:0033613	activating transcription factor binding	1/52	85/17697	0.2218	0.3741	0.3309	NFE2L2	1
MF	GO:0038024	cargo receptor activity	1/52	85/17697	0.2218	0.3741	0.3309	LRP12	1
MF	GO:0030165	PDZ domain binding	1/52	86/17697	0.2241	0.3747	0.3314	ACVR2A	1
MF	GO:0008276	protein methyltransferase activity	1/52	87/17697	0.2264	0.3753	0.3319	PRDM7	1
MF	GO:0005253	anion channel activity	1/52	89/17697	0.2309	0.3796	0.3358	CLCNKA	1
MF	GO:0003924	GTPase activity	2/52	324/17697	0.2464	0.3955	0.3498	RAB3A/RRAGD	2
MF	GO:0004896	cytokine receptor activity	1/52	96/17697	0.2467	0.3955	0.3498	CCR7	1
MF	GO:0008170	N-methyltransferase activity	1/52	96/17697	0.2467	0.3955	0.3498	PRDM7	1
MF	GO:0000980	RNA polymerase II distal enhancer sequence-specific DNA binding	1/52	99/17697	0.2533	0.4028	0.3563	NFE2L2	1
MF	GO:0015108	chloride transmembrane transporter activity	1/52	100/17697	0.2555	0.403	0.3565	CLCNKA	1
MF	GO:0005200	structural constituent of cytoskeleton	1/52	102/17697	0.2599	0.4067	0.3597	DES	1
MF	GO:0047485	protein N-terminus binding	1/52	109/17697	0.2751	0.4269	0.3775	ERCC2	1
MF	GO:1902936	phosphatidylinositol bisphosphate binding	1/52	110/17697	0.2773	0.4269	0.3775	PLEK2	1
MF	GO:0033218	amide binding	2/52	356/17697	0.2814	0.4285	0.3789	CD1B/C1QA	2
MF	GO:0004540	ribonuclease activity	1/52	114/17697	0.2858	0.4285	0.3789	TSEN54	1
MF	GO:0001158	enhancer sequence-specific DNA binding	1/52	119/17697	0.2963	0.4285	0.3789	NFE2L2	1
MF	GO:0016616	oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	1/52	119/17697	0.2963	0.4285	0.3789	RDH8	1
MF	GO:0031490	chromatin DNA binding	1/52	119/17697	0.2963	0.4285	0.3789	PRDM7	1
MF	GO:0005525	GTP binding	2/52	374/17697	0.301	0.4285	0.3789	RAB3A/RRAGD	2
MF	GO:0004857	enzyme inhibitor activity	2/52	375/17697	0.3021	0.4285	0.3789	PPP1R12A/C3	2
MF	GO:0005179	hormone activity	1/52	122/17697	0.3025	0.4285	0.3789	THPO	1
MF	GO:0140101	catalytic activity, acting on a tRNA	1/52	122/17697	0.3025	0.4285	0.3789	TSEN54	1
MF	GO:0032550	purine ribonucleoside binding	2/52	378/17697	0.3054	0.4285	0.3789	RAB3A/RRAGD	2
MF	GO:0001883	purine nucleoside binding	2/52	381/17697	0.3086	0.4285	0.3789	RAB3A/RRAGD	2
MF	GO:0032549	ribonucleoside binding	2/52	382/17697	0.3097	0.4285	0.3789	RAB3A/RRAGD	2
MF	GO:0004519	endonuclease activity	1/52	127/17697	0.3128	0.4285	0.3789	TSEN54	1
MF	GO:0140098	catalytic activity, acting on RNA	2/52	386/17697	0.3141	0.4285	0.3789	TSEN54/DDX3Y	2
MF	GO:0016614	oxidoreductase activity, acting on CH-OH group of donors	1/52	128/17697	0.3148	0.4285	0.3789	RDH8	1
MF	GO:0019955	cytokine binding	1/52	128/17697	0.3148	0.4285	0.3789	CCR7	1
MF	GO:0001882	nucleoside binding	2/52	389/17697	0.3173	0.4285	0.3789	RAB3A/RRAGD	2
MF	GO:0051082	unfolded protein binding	1/52	131/17697	0.3209	0.4285	0.3789	APCS	1
MF	GO:0019001	guanyl nucleotide binding	2/52	394/17697	0.3227	0.4285	0.3789	RAB3A/RRAGD	2
MF	GO:0032561	guanyl ribonucleotide binding	2/52	394/17697	0.3227	0.4285	0.3789	RAB3A/RRAGD	2
MF	GO:0035326	enhancer binding	1/52	133/17697	0.3249	0.4285	0.3789	NFE2L2	1
MF	GO:0004713	protein tyrosine kinase activity	1/52	134/17697	0.3269	0.4285	0.3789	LTK	1
MF	GO:0016779	nucleotidyltransferase activity	1/52	137/17697	0.3328	0.4305	0.3807	OAS2	1
MF	GO:0019838	growth factor binding	1/52	137/17697	0.3328	0.4305	0.3807	ACVR2A	1
MF	GO:0019903	protein phosphatase binding	1/52	140/17697	0.3387	0.4352	0.3849	PHACTR4	1
MF	GO:0008528	G protein-coupled peptide receptor activity	1/52	146/17697	0.3504	0.4443	0.393	CCR7	1
MF	GO:0015103	inorganic anion transmembrane transporter activity	1/52	146/17697	0.3504	0.4443	0.393	CLCNKA	1
MF	GO:0001653	peptide receptor activity	1/52	152/17697	0.3619	0.4559	0.4032	CCR7	1
MF	GO:0001085	RNA polymerase II transcription factor binding	1/52	155/17697	0.3675	0.457	0.4042	NFE2L2	1
MF	GO:0008757	S-adenosylmethionine-dependent methyltransferase activity	1/52	155/17697	0.3675	0.457	0.4042	PRDM7	1
MF	GO:0004674	protein serine/threonine kinase activity	2/52	439/17697	0.371	0.4585	0.4055	ACVR2A/ERCC2	2
MF	GO:0003823	antigen binding	1/52	160/17697	0.3768	0.4621	0.4087	CD1B	1
MF	GO:1901981	phosphatidylinositol phosphate binding	1/52	161/17697	0.3787	0.4621	0.4087	PLEK2	1
MF	GO:0008083	growth factor activity	1/52	163/17697	0.3824	0.4636	0.41	THPO	1
MF	GO:0004866	endopeptidase inhibitor activity	1/52	175/17697	0.404	0.4868	0.4305	C3	1
MF	GO:0019887	protein kinase regulator activity	1/52	180/17697	0.4128	0.4924	0.4355	CCND2	1
MF	GO:0030414	peptidase inhibitor activity	1/52	182/17697	0.4163	0.4924	0.4355	C3	1
MF	GO:0061135	endopeptidase regulator activity	1/52	182/17697	0.4163	0.4924	0.4355	C3	1
MF	GO:0019902	phosphatase binding	1/52	185/17697	0.4215	0.4955	0.4383	PHACTR4	1
MF	GO:0005244	voltage-gated ion channel activity	1/52	197/17697	0.4417	0.5101	0.4512	CLCNKA	1
MF	GO:0022832	voltage-gated channel activity	1/52	197/17697	0.4417	0.5101	0.4512	CLCNKA	1
MF	GO:0042393	histone binding	1/52	197/17697	0.4417	0.5101	0.4512	NOC2L	1
MF	GO:0004518	nuclease activity	1/52	205/17697	0.4549	0.5222	0.4618	TSEN54	1
MF	GO:0140097	catalytic activity, acting on DNA	1/52	213/17697	0.4677	0.5337	0.4721	ERCC2	1
MF	GO:0008168	methyltransferase activity	1/52	215/17697	0.4709	0.5342	0.4725	PRDM7	1
MF	GO:0061134	peptidase regulator activity	1/52	219/17697	0.4771	0.5368	0.4748	C3	1
MF	GO:0005125	cytokine activity	1/52	220/17697	0.4787	0.5368	0.4748	THPO	1
MF	GO:0016741	transferase activity, transferring one-carbon groups	1/52	226/17697	0.4879	0.544	0.4812	PRDM7	1
MF	GO:0016747	transferase activity, transferring acyl groups other than amino-acyl groups	1/52	232/17697	0.497	0.551	0.4873	LPGAT1	1